{"subject_id":"prov:692fe4fd62d945b390f8542828266dc0","object_id":"prov:b75480cc4092473cba07a480e8a7e439","predicate":"treats","confidence":0.9,"source_documents":["PMC11707539"],"created_at":"2026-01-23T04:21:48.887814+00:00","properties":{"evidence":"This study explores the efficacy of Achillea millefolium L. (A. millefolium) extract, known for its phytoestrogenic properties, in treating OC through hormonal and metabolic modulation.","extraction_method":"llm"}}
{"subject_id":"prov:95d67a0a09024ddf8b1c14705f5d6a24","object_id":"prov:b75480cc4092473cba07a480e8a7e439","predicate":"treats","confidence":0.9,"source_documents":["PMC11707539"],"created_at":"2026-01-23T04:21:48.887839+00:00","properties":{"evidence":"Using a Wistar rat model, OC was induced with 7,12-dimethylbenz(a)anthracene (DMBA), and the effects of A. millefolium, both alone and in combination with paclitaxel (PTX), were evaluated.","extraction_method":"llm"}}
{"subject_id":"prov:7e8ab0a650f64fd5b49df5e0ebf78713","object_id":"prov:203dbae4e6474549a499e733b586143e","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12718677"],"created_at":"2026-01-23T04:21:54.009149+00:00","properties":{"evidence":"Conventionally, BC is recognized as a hormone-dependent cancer, and the estrogen-progesterone and their correlated receptors...","extraction_method":"llm"}}
{"subject_id":"prov:ede33c2f183d40bb81c6010d76177361","object_id":"prov:145ebbec4d5b4102bb503a540ce60733","predicate":"interacts_with","confidence":0.9,"source_documents":["PMC12748135"],"created_at":"2026-01-23T04:21:59.435784+00:00","properties":{"evidence":"Mechanistically, TRIM47 catalyzes K63-linked ubiquitination of polo-like kinase 1 (PLK1), leading to its stabilization and subsequent activation of the NF-κB and MAPK pathways.","extraction_method":"llm"}}
{"subject_id":"prov:c0730ce057f84a94898be2e832b35f53","object_id":"prov:e4b2904e323746b4ae6b1fecf95a558e","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12748365"],"created_at":"2026-01-23T04:22:09.163999+00:00","properties":{"evidence":"RT-qPCR demonstrated significant up-regulation of PIAS1, PIAS2, PIAS3, and PIAS4 in HNSC cell lines.","extraction_method":"llm"}}
{"subject_id":"prov:712ef35359b74f9787ea5668781d7917","object_id":"prov:e4b2904e323746b4ae6b1fecf95a558e","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12748365"],"created_at":"2026-01-23T04:22:09.164029+00:00","properties":{"evidence":"RT-qPCR demonstrated significant up-regulation of PIAS1, PIAS2, PIAS3, and PIAS4 in HNSC cell lines.","extraction_method":"llm"}}
{"subject_id":"prov:762c42909f844bf9a941abb2b00fc535","object_id":"prov:e4b2904e323746b4ae6b1fecf95a558e","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12748365"],"created_at":"2026-01-23T04:22:09.164039+00:00","properties":{"evidence":"RT-qPCR demonstrated significant up-regulation of PIAS1, PIAS2, PIAS3, and PIAS4 in HNSC cell lines.","extraction_method":"llm"}}
{"subject_id":"prov:a9e0fb97b7bb4bfdb473328fa2f0e3e0","object_id":"prov:e4b2904e323746b4ae6b1fecf95a558e","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12748365"],"created_at":"2026-01-23T04:22:09.164047+00:00","properties":{"evidence":"RT-qPCR demonstrated significant up-regulation of PIAS1, PIAS2, PIAS3, and PIAS4 in HNSC cell lines.","extraction_method":"llm"}}
{"subject_id":"prov:232fec2dc98c43e5af5ba1b2ffce0b2f","object_id":"prov:999fcccc6fd84c278f99a04cacd6c78d","predicate":"interacts_with","confidence":0.9,"source_documents":["PMC12748648"],"created_at":"2026-01-23T04:22:13.979728+00:00","properties":{"evidence":"ATM phosphorylates TRIM37 at Th203, promoting its nuclear entry and the monoubiquitination of PARP1,","extraction_method":"llm"}}
{"subject_id":"prov:9200f334a9a945a0a7b25bc2fdc24a20","object_id":"prov:999fcccc6fd84c278f99a04cacd6c78d","predicate":"interacts_with","confidence":0.9,"source_documents":["PMC12748648"],"created_at":"2026-01-23T04:22:13.979752+00:00","properties":{"evidence":"Mechanistically, PARP1 recruits TET1 to hydrolyze methylated nucleotides on DNMT1 exons,","extraction_method":"llm"}}
{"subject_id":"prov:232fec2dc98c43e5af5ba1b2ffce0b2f","object_id":"prov:79774513917042fea4d9c7b2295d808e","predicate":"interacts_with","confidence":0.9,"source_documents":["PMC12748648"],"created_at":"2026-01-23T04:22:13.979758+00:00","properties":{"evidence":"CCTF or TRIM37 knockdown induces replicative senescence of MSCs with loss of full-length DNMT1.","extraction_method":"llm"}}
{"subject_id":"prov:5d2934d5a42c4756967c0f2befd70dae","object_id":"prov:15b7b195b8eb45f3b3b5cf6c048c3922","predicate":"treats","confidence":0.9,"source_documents":["PMC12748648"],"created_at":"2026-01-23T04:22:13.979764+00:00","properties":{"evidence":"Co-treatment with resveratrol (ATM activator) and vitamin C (TET1 activator) rejuvenates late MSCs via the TRIM37/PARP1/DNMT1 pathway and alleviates osteoporosis in aged mice.","extraction_method":"llm"}}
{"subject_id":"prov:025d89658c0a4830b3dd8783d669d3e9","object_id":"prov:15b7b195b8eb45f3b3b5cf6c048c3922","predicate":"treats","confidence":0.9,"source_documents":["PMC12748648"],"created_at":"2026-01-23T04:22:13.979769+00:00","properties":{"evidence":"Co-treatment with resveratrol (ATM activator) and vitamin C (TET1 activator) rejuvenates late MSCs via the TRIM37/PARP1/DNMT1 pathway and alleviates osteoporosis in aged mice.","extraction_method":"llm"}}
{"subject_id":"prov:232fec2dc98c43e5af5ba1b2ffce0b2f","object_id":"prov:15b7b195b8eb45f3b3b5cf6c048c3922","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12748648"],"created_at":"2026-01-23T04:22:13.979773+00:00","properties":{"evidence":"CCTF or TRIM37 knockdown induces replicative senescence of MSCs with loss of full-length DNMT1.","extraction_method":"llm"}}
{"subject_id":"prov:999fcccc6fd84c278f99a04cacd6c78d","object_id":"prov:15b7b195b8eb45f3b3b5cf6c048c3922","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12748648"],"created_at":"2026-01-23T04:22:13.979778+00:00","properties":{"evidence":"CCTF or TRIM37 knockdown induces replicative senescence of MSCs with loss of full-length DNMT1.","extraction_method":"llm"}}
{"subject_id":"prov:d8de0316610f45088c6bcd613b9fbf9d","object_id":"prov:f97ceee649e8432c9687bf6cc9787992","predicate":"causes","confidence":0.8,"source_documents":["PMC12750060"],"created_at":"2026-01-23T04:22:34.662594+00:00","properties":{"evidence":"乳腺癌本身及其抗肿瘤治疗（如化疗、放疗、内分泌治疗、靶向治疗和免疫治疗等）均对女性生育能力造成影响。","extraction_method":"llm"}}
{"subject_id":"prov:d8de0316610f45088c6bcd613b9fbf9d","object_id":"prov:940a7022908a4dbdba7be5c1e57e3ceb","predicate":"increases_risk","confidence":0.7,"source_documents":["PMC12750060"],"created_at":"2026-01-23T04:22:34.662618+00:00","properties":{"evidence":"乳腺癌患者的生育率明显低于同龄普通人群。","extraction_method":"llm"}}
{"subject_id":"prov:f97ceee649e8432c9687bf6cc9787992","object_id":"prov:d8de0316610f45088c6bcd613b9fbf9d","predicate":"prevents","confidence":0.9,"source_documents":["PMC12750060"],"created_at":"2026-01-23T04:22:34.662624+00:00","properties":{"evidence":"通过药物、手术及辅助生殖技术等生育力保存措施，避免或减轻治疗对乳腺癌患者生育能力造成的损害。","extraction_method":"llm"}}
{"subject_id":"prov:940a7022908a4dbdba7be5c1e57e3ceb","object_id":"prov:d8de0316610f45088c6bcd613b9fbf9d","predicate":"associated_with","confidence":0.8,"source_documents":["PMC12750060"],"created_at":"2026-01-23T04:22:34.662629+00:00","properties":{"evidence":"中国乳腺癌患者发病年龄较小，年轻患者的生育问题已成为临床和社会共同面临的现实挑战。","extraction_method":"llm"}}
{"subject_id":"prov:34b6115e7c3c4b8c82bacf877639edc5","object_id":"prov:5e467240cdb94af99d602e6d6f737557","predicate":"causes","confidence":0.9,"source_documents":["PMC12750178"],"created_at":"2026-01-23T04:22:38.552856+00:00","properties":{"evidence":"The integration of ferroptosis induction with cancer immunotherapy has emerged as a promising approach in oncology","extraction_method":"llm"}}
{"subject_id":"prov:b468f4503d1347dea911986c3a532598","object_id":"prov:292d1b8aa1ee440ba8195826dd5f0f2b","predicate":"increases_risk","confidence":0.8,"source_documents":["PMC12750178"],"created_at":"2026-01-23T04:22:38.552879+00:00","properties":{"evidence":"By inducing lipid peroxidation in tumor tissues, ferroptotic tumor cell death can stimulate immunogenicity","extraction_method":"llm"}}
{"subject_id":"prov:b468f4503d1347dea911986c3a532598","object_id":"prov:b3d3da947c2448cf9ed43794ec14faa3","predicate":"increases_risk","confidence":0.7,"source_documents":["PMC12750178"],"created_at":"2026-01-23T04:22:38.552885+00:00","properties":{"evidence":"excessive lipid peroxidation may paradoxically impair the functionality of multiple immune cells","extraction_method":"llm"}}
{"subject_id":"prov:34b6115e7c3c4b8c82bacf877639edc5","object_id":"prov:5e467240cdb94af99d602e6d6f737557","predicate":"treats","confidence":0.9,"source_documents":["PMC12750178"],"created_at":"2026-01-23T04:22:38.552890+00:00","properties":{"evidence":"The integration of ferroptosis induction with cancer immunotherapy has emerged as a promising approach in oncology","extraction_method":"llm"}}
{"subject_id":"prov:e690589685ab4236be476bb27367f08f","object_id":"prov:292d1b8aa1ee440ba8195826dd5f0f2b","predicate":"associated_with","confidence":0.8,"source_documents":["PMC12750178"],"created_at":"2026-01-23T04:22:38.552910+00:00","properties":{"evidence":"By inducing lipid peroxidation in tumor tissues, ferroptotic tumor cell death can stimulate immunogenicity","extraction_method":"llm"}}
{"subject_id":"prov:2e618c994b484da78b66b9246090f76c","object_id":"prov:5e467240cdb94af99d602e6d6f737557","predicate":"treats","confidence":0.9,"source_documents":["PMC12750178"],"created_at":"2026-01-23T04:22:38.552915+00:00","properties":{"evidence":"To address these crosstalk challenges, several advanced drug delivery strategies have been proposed","extraction_method":"llm"}}
{"subject_id":"prov:fa5033f72a554272847af0d4243fc921","object_id":"prov:5e467240cdb94af99d602e6d6f737557","predicate":"treats","confidence":0.8,"source_documents":["PMC12750178"],"created_at":"2026-01-23T04:22:38.552919+00:00","properties":{"evidence":"To address these crosstalk challenges, several advanced drug delivery strategies have been proposed","extraction_method":"llm"}}
{"subject_id":"prov:b68057d412ab41dc89d1073a9738a469","object_id":"prov:5e467240cdb94af99d602e6d6f737557","predicate":"treats","confidence":0.9,"source_documents":["PMC12750178"],"created_at":"2026-01-23T04:22:38.552924+00:00","properties":{"evidence":"To address these crosstalk challenges, several advanced drug delivery strategies have been proposed","extraction_method":"llm"}}
{"subject_id":"prov:9d71279e81794e9999be393157407ad9","object_id":"prov:ee35c66be7194e6eaf7ff63b5fcd8769","predicate":"treats","confidence":0.9,"source_documents":["PMC12750853"],"created_at":"2026-01-23T04:22:48.582915+00:00","properties":{"evidence":"In vivo, the combination therapy achieved a 95–100% reduction in tumor burden,","extraction_method":"llm"}}
{"subject_id":"prov:45a5f8556cf9458cabf7acc83eba65ad","object_id":"prov:ee35c66be7194e6eaf7ff63b5fcd8769","predicate":"treats","confidence":0.9,"source_documents":["PMC12750853"],"created_at":"2026-01-23T04:22:48.582905+00:00","properties":{"evidence":"In vivo, the combination therapy achieved a 95–100% reduction in tumor burden,","extraction_method":"llm"}}
{"subject_id":"prov:9d71279e81794e9999be393157407ad9","object_id":"prov:a2e67bd997294d62879365aae1c858d7","predicate":"increases_risk","confidence":0.8,"source_documents":["PMC12750853"],"created_at":"2026-01-23T04:22:48.582798+00:00","properties":{"evidence":"While poly (ADP-ribose) polymerase inhibitors (PARPi) show efficacy in TNBCs with DNA repair deficiencies,","extraction_method":"llm"}}
{"subject_id":"prov:45a5f8556cf9458cabf7acc83eba65ad","object_id":"prov:a2e67bd997294d62879365aae1c858d7","predicate":"increases_risk","confidence":0.8,"source_documents":["PMC12750853"],"created_at":"2026-01-23T04:22:48.582818+00:00","properties":{"evidence":"Here, we introduce a novel gene-chemotherapy combining our mitochondria-targeted luminoptogenetics technology (cmLumiOpto), which directly disrupts mitochondrial membrane potential and induces cancer cell death,","extraction_method":"llm"}}
{"subject_id":"prov:9d71279e81794e9999be393157407ad9","object_id":"prov:a2e67bd997294d62879365aae1c858d7","predicate":"associated_with","confidence":0.8,"source_documents":["PMC12750853"],"created_at":"2026-01-23T04:22:48.582829+00:00","properties":{"evidence":"While poly (ADP-ribose) polymerase inhibitors (PARPi) show efficacy in TNBCs with DNA repair deficiencies,","extraction_method":"llm"}}
{"subject_id":"prov:45a5f8556cf9458cabf7acc83eba65ad","object_id":"prov:a2e67bd997294d62879365aae1c858d7","predicate":"associated_with","confidence":0.8,"source_documents":["PMC12750853"],"created_at":"2026-01-23T04:22:48.582836+00:00","properties":{"evidence":"Here, we introduce a novel gene-chemotherapy combining our mitochondria-targeted luminoptogenetics technology (cmLumiOpto), which directly disrupts mitochondrial membrane potential and induces cancer cell death,","extraction_method":"llm"}}
{"subject_id":"prov:9d71279e81794e9999be393157407ad9","object_id":"prov:45a5f8556cf9458cabf7acc83eba65ad","predicate":"interacts_with","confidence":0.9,"source_documents":["PMC12750853"],"created_at":"2026-01-23T04:22:48.582844+00:00","properties":{"evidence":"Here, we introduce a novel gene-chemotherapy combining our mitochondria-targeted luminoptogenetics technology (cmLumiOpto), which directly disrupts mitochondrial membrane potential and induces cancer cell death,","extraction_method":"llm"}}
{"subject_id":"prov:9d71279e81794e9999be393157407ad9","object_id":"prov:ee35c66be7194e6eaf7ff63b5fcd8769","predicate":"increases_risk","confidence":0.8,"source_documents":["PMC12750853"],"created_at":"2026-01-23T04:22:48.582929+00:00","properties":{"evidence":"Post-treatment analyses confirmed mitochondrial depolarization,","extraction_method":"llm"}}
{"subject_id":"prov:45a5f8556cf9458cabf7acc83eba65ad","object_id":"prov:ee35c66be7194e6eaf7ff63b5fcd8769","predicate":"increases_risk","confidence":0.8,"source_documents":["PMC12750853"],"created_at":"2026-01-23T04:22:48.582922+00:00","properties":{"evidence":"Post-treatment analyses confirmed mitochondrial depolarization,","extraction_method":"llm"}}
{"subject_id":"prov:9d71279e81794e9999be393157407ad9","object_id":"prov:ee35c66be7194e6eaf7ff63b5fcd8769","predicate":"associated_with","confidence":0.8,"source_documents":["PMC12750853"],"created_at":"2026-01-23T04:22:48.582946+00:00","properties":{"evidence":"Post-treatment analyses confirmed mitochondrial depolarization,","extraction_method":"llm"}}
{"subject_id":"prov:45a5f8556cf9458cabf7acc83eba65ad","object_id":"prov:ee35c66be7194e6eaf7ff63b5fcd8769","predicate":"associated_with","confidence":0.8,"source_documents":["PMC12750853"],"created_at":"2026-01-23T04:22:48.582936+00:00","properties":{"evidence":"Post-treatment analyses confirmed mitochondrial depolarization,","extraction_method":"llm"}}
{"subject_id":"prov:45a5f8556cf9458cabf7acc83eba65ad","object_id":"prov:9d71279e81794e9999be393157407ad9","predicate":"interacts_with","confidence":0.9,"source_documents":["PMC12750853"],"created_at":"2026-01-23T04:22:48.582898+00:00","properties":{"evidence":"In vitro studies confirmed successful transfection, internalization, and functional expression of cmLumiOpto, leading to significantly enhanced cytotoxicity when combined with PARPi.","extraction_method":"llm"}}
{"subject_id":"prov:49246f5fdc304760a63236afcd54c411","object_id":"prov:fc701c68a8ee4c4faf860a11f15a740a","predicate":"inhibits","confidence":0.9,"source_documents":["PMC12751073"],"created_at":"2026-01-23T04:22:50.276276+00:00","properties":{"evidence":"Here, we report an unexpected mechanism by which CaM can bind CHK2 kinase to inhibit its kinase activity.","extraction_method":"llm"}}
{"subject_id":"prov:96f0cd350c81411baaca8d2f30efcce9","object_id":"prov:d9bf26024fde42de9e72434dd239fdc2","predicate":"associated_with","confidence":0.7,"source_documents":["PMC12751073"],"created_at":"2026-01-23T04:22:50.276340+00:00","properties":{"evidence":"Our findings add direct suppression of kinase activity to the repertoire of CaM’s functions, complementing the paradigmatic mechanism of promoting kinase activity through autoinhibitory domain sequestration.","extraction_method":"llm"}}
{"subject_id":"prov:bb738f404108461b88c6c51a2e16c62b","object_id":"prov:0e4a8150647846d5b7f690660882d1d6","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12751080"],"created_at":"2026-01-23T04:22:54.123409+00:00","properties":{"evidence":"SUMOylation, a protein post-translational modification (PTM) involving the covalent attachment of small ubiquitin-like modifier (SUMO)","extraction_method":"llm"}}
{"subject_id":"prov:eff463c7823446ffa4e7241513b98f5b","object_id":"prov:0a2ed400823d4d8fa5c3fa3b391970de","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12751080"],"created_at":"2026-01-23T04:22:54.123454+00:00","properties":{"evidence":"including SUMO E3 ligases and downstream effector proteins such as transcription factors","extraction_method":"llm"}}
{"subject_id":"prov:eff463c7823446ffa4e7241513b98f5b","object_id":"prov:10fb3b5205504147beb6a9cf54233bcb","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12751080"],"created_at":"2026-01-23T04:22:54.123466+00:00","properties":{"evidence":"including SUMO E3 ligases and downstream effector proteins such as transcription factors","extraction_method":"llm"}}
{"subject_id":"prov:eff463c7823446ffa4e7241513b98f5b","object_id":"prov:c10d879bfd2a4038a0bc99a7358ca3aa","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12751080"],"created_at":"2026-01-23T04:22:54.123492+00:00","properties":{"evidence":"including SUMO E3 ligases and downstream effector proteins such as transcription factors","extraction_method":"llm"}}
{"subject_id":"prov:0a2ed400823d4d8fa5c3fa3b391970de","object_id":"prov:10fb3b5205504147beb6a9cf54233bcb","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12751080"],"created_at":"2026-01-23T04:22:54.123506+00:00","properties":{"evidence":"including SUMO E3 ligases and downstream effector proteins such as transcription factors","extraction_method":"llm"}}
{"subject_id":"prov:0a2ed400823d4d8fa5c3fa3b391970de","object_id":"prov:c10d879bfd2a4038a0bc99a7358ca3aa","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12751080"],"created_at":"2026-01-23T04:22:54.123520+00:00","properties":{"evidence":"including SUMO E3 ligases and downstream effector proteins such as transcription factors","extraction_method":"llm"}}
{"subject_id":"prov:10fb3b5205504147beb6a9cf54233bcb","object_id":"prov:c10d879bfd2a4038a0bc99a7358ca3aa","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12751080"],"created_at":"2026-01-23T04:22:54.123530+00:00","properties":{"evidence":"including SUMO E3 ligases and downstream effector proteins such as transcription factors","extraction_method":"llm"}}
{"subject_id":"prov:317f4e485d6a4305a72d5d54524511d4","object_id":"prov:ea32991bd7ea4d66876e8624f8cab04e","predicate":"causes","confidence":0.9,"source_documents":["PMC12751341"],"created_at":"2026-01-23T04:22:57.092559+00:00","properties":{"evidence":"The internal characteristics of TNBC are extraordinary complex and are accompanied by numerous gene mutations...","extraction_method":"llm"}}
{"subject_id":"prov:ea32991bd7ea4d66876e8624f8cab04e","object_id":"prov:654abfcaced243b3bc6c737e22ec40bf","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12751341"],"created_at":"2026-01-23T04:22:57.092629+00:00","properties":{"evidence":"constitutively activated signaling networks...","extraction_method":"llm"}}
{"subject_id":"prov:f260a0829d164eb699d6daf174ecc202","object_id":"prov:317f4e485d6a4305a72d5d54524511d4","predicate":"treats","confidence":0.8,"source_documents":["PMC12751341"],"created_at":"2026-01-23T04:22:57.092638+00:00","properties":{"evidence":"Subsequently, we summarized the corresponding targeted therapeutic drugs, and reviewed the current targeted TNBC therapies launched in clinical trials...","extraction_method":"llm"}}
{"subject_id":"prov:f5e0c175846743bebc68c41c42f4acd2","object_id":"prov:ce7a91bbf6b642f4ae4b317ff2232456","predicate":"treats","confidence":0.9,"source_documents":["PMC12752834"],"created_at":"2026-01-23T04:23:01.080735+00:00","properties":{"evidence":"This study screened a total of 366 targets for the JPXK recipe, 1886 T2DM‐related targets, and 214 intersecting targets.","extraction_method":"llm"}}
{"subject_id":"prov:cba7b28ac65140baa1d65cd1873aca92","object_id":"prov:1af967ab5a444595b3e47a09d332e1e3","predicate":"interacts_with","confidence":0.8,"source_documents":["PMC12752834"],"created_at":"2026-01-23T04:23:01.080756+00:00","properties":{"evidence":"Molecular docking results showed that quercetin combined best with the hub gene JUN.","extraction_method":"llm"}}
{"subject_id":"prov:413da1b759e24bcf8e04cb44f737f623","object_id":"prov:12479e851720423c8d6ac57f58b99207","predicate":"interacts_with","confidence":0.8,"source_documents":["PMC12752834"],"created_at":"2026-01-23T04:23:01.080763+00:00","properties":{"evidence":"Molecular docking results showed that luteolin combined best with the hub gene FOS.","extraction_method":"llm"}}
{"subject_id":"prov:1af967ab5a444595b3e47a09d332e1e3","object_id":"prov:cba7b28ac65140baa1d65cd1873aca92","predicate":"interacts_with","confidence":0.8,"source_documents":["PMC12752834"],"created_at":"2026-01-23T04:23:01.080775+00:00","properties":{"evidence":"Molecular docking results showed that quercetin combined best with the hub gene JUN.","extraction_method":"llm"}}
{"subject_id":"prov:12479e851720423c8d6ac57f58b99207","object_id":"prov:413da1b759e24bcf8e04cb44f737f623","predicate":"interacts_with","confidence":0.8,"source_documents":["PMC12752834"],"created_at":"2026-01-23T04:23:01.080780+00:00","properties":{"evidence":"Molecular docking results showed that luteolin combined best with the hub gene FOS.","extraction_method":"llm"}}
{"subject_id":"prov:62ccd31bfbda4aaaa4f1495fcc38d45c","object_id":"prov:cba7b28ac65140baa1d65cd1873aca92","predicate":"interacts_with","confidence":0.7,"source_documents":["PMC12752834"],"created_at":"2026-01-23T04:23:01.080784+00:00","properties":{"evidence":"JUN, FOS, AKT1, RELA, and MAPK3 interacted well with these critical ingredients.","extraction_method":"llm"}}
{"subject_id":"prov:e716018486e74b079aecd88c53099be9","object_id":"prov:413da1b759e24bcf8e04cb44f737f623","predicate":"interacts_with","confidence":0.7,"source_documents":["PMC12752834"],"created_at":"2026-01-23T04:23:01.080789+00:00","properties":{"evidence":"JUN, FOS, AKT1, RELA, and MAPK3 interacted well with these critical ingredients.","extraction_method":"llm"}}
{"subject_id":"prov:51039c1d87054afc87abf711200b2571","object_id":"prov:cba7b28ac65140baa1d65cd1873aca92","predicate":"interacts_with","confidence":0.7,"source_documents":["PMC12752834"],"created_at":"2026-01-23T04:23:01.080794+00:00","properties":{"evidence":"JUN, FOS, AKT1, RELA, and MAPK3 interacted well with these critical ingredients.","extraction_method":"llm"}}
{"subject_id":"prov:f8246ac0249e4f0594c1209266df970a","object_id":"prov:ef7310eb117346ba9792a665a0f03a0b","predicate":"causes","confidence":0.9,"source_documents":["PMC12753587"],"created_at":"2026-01-23T04:23:02.616274+00:00","properties":{"evidence":"Highlights PTBP1 disruption induces ferroptosis in EC cells.","extraction_method":"llm"}}
{"subject_id":"prov:0cb86d4c5ac6465c853c72d5f0d371c1","object_id":"prov:6248660ae9c84b799edd15740c329a95","predicate":"treats","confidence":0.9,"source_documents":["PMC12753621"],"created_at":"2026-01-23T04:23:09.580920+00:00","properties":{"evidence":"Recent advancements in cancer treatment, including targeted therapy, tailored vaccines, immunotherapy, and bacteriotherapy, have demonstrated remarkable potential in addressing various types of cancer.","extraction_method":"llm"}}
{"subject_id":"prov:0cb86d4c5ac6465c853c72d5f0d371c1","object_id":"prov:ad48106350184d45b60444a6ac24853c","predicate":"treats","confidence":0.9,"source_documents":["PMC12753621"],"created_at":"2026-01-23T04:23:09.580946+00:00","properties":{"evidence":"This study explored the potential of tailored vaccinations, immunotherapy, CRISPR/Cas9, and bacteriotherapy for cancer treatment.","extraction_method":"llm"}}
{"subject_id":"prov:0cb86d4c5ac6465c853c72d5f0d371c1","object_id":"prov:63ac1063d92a4722956e9c68c9bbb310","predicate":"treats","confidence":0.9,"source_documents":["PMC12753621"],"created_at":"2026-01-23T04:23:09.580953+00:00","properties":{"evidence":"This study explored the potential of tailored vaccinations, immunotherapy, CRISPR/Cas9, and bacteriotherapy for cancer treatment.","extraction_method":"llm"}}
{"subject_id":"prov:0cb86d4c5ac6465c853c72d5f0d371c1","object_id":"prov:e091e70bfc2f4379b756fde772671308","predicate":"treats","confidence":0.9,"source_documents":["PMC12753621"],"created_at":"2026-01-23T04:23:09.580959+00:00","properties":{"evidence":"The CRISPR-Cas9 genome-editing technique shows promise for advancing cancer treatment, with the potential to target and treat genetic mutations at the tumor level,","extraction_method":"llm"}}
{"subject_id":"prov:0cb86d4c5ac6465c853c72d5f0d371c1","object_id":"prov:52c9faef56d349ffb60394278da07b84","predicate":"causes","confidence":0.8,"source_documents":["PMC12753621"],"created_at":"2026-01-23T04:23:09.580964+00:00","properties":{"evidence":"the potential for tumor cell resistance to pharmacological agents","extraction_method":"llm"}}
{"subject_id":"prov:e9f1e7b0fe594d319c67f255c6024f9c","object_id":"prov:52c9faef56d349ffb60394278da07b84","predicate":"increases_risk","confidence":0.8,"source_documents":["PMC12753621"],"created_at":"2026-01-23T04:23:09.580969+00:00","properties":{"evidence":"the potential for tumor cell resistance to pharmacological agents","extraction_method":"llm"}}
{"subject_id":"prov:ad48106350184d45b60444a6ac24853c","object_id":"prov:5b7a2958f50647fab4e067cfdcbb261f","predicate":"indicates","confidence":0.9,"source_documents":["PMC12753621"],"created_at":"2026-01-23T04:23:09.580974+00:00","properties":{"evidence":"This research highlights the promising use of personalized cancer vaccines, which induce tumor-specific immune responses targeting neoantigens unique to each patient.","extraction_method":"llm"}}
{"subject_id":"prov:207d3ed44f8f450a9da6c408fce90c4b","object_id":"prov:0cb86d4c5ac6465c853c72d5f0d371c1","predicate":"treats","confidence":0.9,"source_documents":["PMC12753621"],"created_at":"2026-01-23T04:23:09.580980+00:00","properties":{"evidence":"While the effectiveness of immunotherapies, such as immune checkpoint inhibitors (ICIs) and adoptive cell transfer (ACT), is variable,","extraction_method":"llm"}}
{"subject_id":"prov:f28926afb2b94ae0bf349dae349699b4","object_id":"prov:0cb86d4c5ac6465c853c72d5f0d371c1","predicate":"treats","confidence":0.9,"source_documents":["PMC12753621"],"created_at":"2026-01-23T04:23:09.580985+00:00","properties":{"evidence":"While the effectiveness of immunotherapies, such as immune checkpoint inhibitors (ICIs) and adoptive cell transfer (ACT), is variable,","extraction_method":"llm"}}
{"subject_id":"prov:63ac1063d92a4722956e9c68c9bbb310","object_id":"prov:0cb86d4c5ac6465c853c72d5f0d371c1","predicate":"treats","confidence":0.9,"source_documents":["PMC12753621"],"created_at":"2026-01-23T04:23:09.580989+00:00","properties":{"evidence":"Bacteriotherapy has also proven effective in promoting tumor remission and inhibiting metastasis,","extraction_method":"llm"}}
{"subject_id":"prov:e091e70bfc2f4379b756fde772671308","object_id":"prov:b3a40088ec164cbd8782c5864a58f7cf","predicate":"associated_with","confidence":0.8,"source_documents":["PMC12753621"],"created_at":"2026-01-23T04:23:09.581027+00:00","properties":{"evidence":"The CRISPR-Cas9 genome-editing technique shows promise for advancing cancer treatment, with the potential to target and treat genetic mutations at the tumor level,","extraction_method":"llm"}}
{"subject_id":"prov:63ac1063d92a4722956e9c68c9bbb310","object_id":"prov:b3a40088ec164cbd8782c5864a58f7cf","predicate":"interacts_with","confidence":0.8,"source_documents":["PMC12753621"],"created_at":"2026-01-23T04:23:09.581037+00:00","properties":{"evidence":"Additionally, bacteriotherapy serves as a potential platform for delivering therapeutics, genes, or medications directly to tumors.","extraction_method":"llm"}}
{"subject_id":"prov:16d99a19a9d64eae91a5d1ffc4d47395","object_id":"prov:57d7f8f6916b4cb79d533f0b0aa58eaa","predicate":"associated_with","confidence":0.8,"source_documents":["PMC12753947"],"created_at":"2026-01-23T04:23:12.139775+00:00","properties":{"evidence":"This review systematically integrates recent advances from histological, molecular, and epidemiological studies to comprehensively evaluate the potential associations between HPV infection and different types of thyroid disorders.","extraction_method":"llm"}}
{"subject_id":"prov:8681ecc9a5a2402d9b3c8b643501a762","object_id":"prov:1072f593fb784e268222cd8f9494bdd0","predicate":"causes","confidence":0.9,"source_documents":["PMC12754045"],"created_at":"2026-01-23T04:23:16.345223+00:00","properties":{"evidence":"which can lead to decisional conflict (DC) and uncertainty in patients.","extraction_method":"llm"}}
{"subject_id":"prov:cec7e77665b34844a541fb188217ad53","object_id":"prov:1072f593fb784e268222cd8f9494bdd0","predicate":"diagnosed_by","confidence":0.8,"source_documents":["PMC12754045"],"created_at":"2026-01-23T04:23:16.345247+00:00","properties":{"evidence":"Patient-perceived SDM was measured by the SDM Questionnaire-9 (SDM-Q-9) and perceived DC by the DC Scale (DCS)","extraction_method":"llm"}}
{"subject_id":"prov:cec7e77665b34844a541fb188217ad53","object_id":"prov:1072f593fb784e268222cd8f9494bdd0","predicate":"associated_with","confidence":0.8,"source_documents":["PMC12754045"],"created_at":"2026-01-23T04:23:16.345253+00:00","properties":{"evidence":"Patient-perceived SDM was measured by the SDM Questionnaire-9 (SDM-Q-9) and perceived DC by the DC Scale (DCS)","extraction_method":"llm"}}
{"subject_id":"prov:9b53e44d961d435fb7f4ab329c71f37a","object_id":"prov:1072f593fb784e268222cd8f9494bdd0","predicate":"diagnosed_by","confidence":0.8,"source_documents":["PMC12754045"],"created_at":"2026-01-23T04:23:16.345258+00:00","properties":{"evidence":"Surgeons’ perceptions of SDM were measured by the SDM-Q-Doc","extraction_method":"llm"}}
{"subject_id":"prov:0f25ea6ec49a47c2a8a6266f40b747b8","object_id":"prov:ae610a8b9c6a4badaeb3b0fe81b9c14b","predicate":"causes","confidence":0.9,"source_documents":["PMC12754092"],"created_at":"2026-01-23T04:23:21.374199+00:00","properties":{"evidence":"BACKGROUND Helicobacter pylori (H. pylori) infection is widely considered to be a major risk factor for gastric cancer","extraction_method":"llm"}}
{"subject_id":"prov:36cd4cc535624621860f7122382ae336","object_id":"prov:ae610a8b9c6a4badaeb3b0fe81b9c14b","predicate":"associated_with","confidence":0.8,"source_documents":["PMC12754092"],"created_at":"2026-01-23T04:23:21.374244+00:00","properties":{"evidence":"However, the role of YY1 in the inflammatory transformation associated with H. pylori-induced gastric cancer remains unclear.","extraction_method":"llm"}}
{"subject_id":"prov:36cd4cc535624621860f7122382ae336","object_id":"prov:ae610a8b9c6a4badaeb3b0fe81b9c14b","predicate":"increases_risk","confidence":0.8,"source_documents":["PMC12754092"],"created_at":"2026-01-23T04:23:21.374254+00:00","properties":{"evidence":"Kaplan-Meier survival curves indicated that high YY1 expression correlated with a poor prognosis.","extraction_method":"llm"}}
{"subject_id":"prov:629aa139e4a340379f0acea14e56ac2e","object_id":"prov:36cd4cc535624621860f7122382ae336","predicate":"interacts_with","confidence":0.8,"source_documents":["PMC12754092"],"created_at":"2026-01-23T04:23:21.374263+00:00","properties":{"evidence":"YY1 and JAK2 interaction was validated by chromatin immunoprecipitation.","extraction_method":"llm"}}
{"subject_id":"prov:303072beb8e34af6a154440b3fd6dd89","object_id":"prov:ae610a8b9c6a4badaeb3b0fe81b9c14b","predicate":"associated_with","confidence":0.7,"source_documents":["PMC12754092"],"created_at":"2026-01-23T04:23:21.374271+00:00","properties":{"evidence":"Expression of YY1, members of the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling pathway, and epithelial-mesenchymal transition (EMT)-related proteins in gastric cancer was examined","extraction_method":"llm"}}
{"subject_id":"prov:0b76b9ae25014a2e8ffa9fad98911798","object_id":"prov:e312139e97074c3da1cb1040b2d6d225","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12754332"],"created_at":"2026-01-23T04:23:24.940163+00:00","properties":{"evidence":"For example, microRNAs such as miR-141-3p and miR-630 enhance CRC radiosensitivity by targeting oncogenic pathways.","extraction_method":"llm"}}
{"subject_id":"prov:c6f93864bc7b494bb7ef9aae4657ac00","object_id":"prov:e312139e97074c3da1cb1040b2d6d225","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12754332"],"created_at":"2026-01-23T04:23:24.940174+00:00","properties":{"evidence":"For example, microRNAs such as miR-141-3p and miR-630 enhance CRC radiosensitivity by targeting oncogenic pathways.","extraction_method":"llm"}}
{"subject_id":"prov:1c26d05c513b46418cb25ffdb29b2b59","object_id":"prov:e312139e97074c3da1cb1040b2d6d225","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12754332"],"created_at":"2026-01-23T04:23:24.940210+00:00","properties":{"evidence":"In addition, lncRNAs, including the lncRNAs HOTAIR and LINC00630, influence the radiosensitivity of CRC through interactions with the DNA damage repair machinery and epigenetic modulators, respectively.","extraction_method":"llm"}}
{"subject_id":"prov:1576f6a4ff994895a74860e58ace3a8d","object_id":"prov:e312139e97074c3da1cb1040b2d6d225","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12754332"],"created_at":"2026-01-23T04:23:24.940219+00:00","properties":{"evidence":"In addition, lncRNAs, including the lncRNAs HOTAIR and LINC00630, influence the radiosensitivity of CRC through interactions with the DNA damage repair machinery and epigenetic modulators, respectively.","extraction_method":"llm"}}
{"subject_id":"prov:9402aa82119f48c5b480028facfae777","object_id":"prov:e312139e97074c3da1cb1040b2d6d225","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12754332"],"created_at":"2026-01-23T04:23:24.940228+00:00","properties":{"evidence":"In addition, circ_0124554 acts as a competitive endogenous RNA to regulate oncogenic signaling.","extraction_method":"llm"}}
{"subject_id":"prov:f4ca3ba0b2d946508550acd9673a490f","object_id":"prov:6d449d0e361346428b3b342e491987f5","predicate":"inhibits","confidence":0.9,"source_documents":["PMC12754786"],"created_at":"2026-01-23T04:23:35.798173+00:00","properties":{"evidence":"replication-dependent and PARP1/PARP2-mediated PARylation recruits the base excision repair (BER)/single-strand break repair (SSBR) scaffold protein XRCC1...","extraction_method":"llm"}}
{"subject_id":"prov:f4ca3ba0b2d946508550acd9673a490f","object_id":"prov:ebd9965d69db467aa1de8f7ca0e6b02e","predicate":"inhibits","confidence":0.9,"source_documents":["PMC12754786"],"created_at":"2026-01-23T04:23:35.798215+00:00","properties":{"evidence":"replication-dependent and PARP1/PARP2-mediated PARylation recruits the base excision repair (BER)/single-strand break repair (SSBR) scaffold protein XRCC1...","extraction_method":"llm"}}
{"subject_id":"prov:401d504013204ca4ae526c0e75d4d5bc","object_id":"prov:ebd9965d69db467aa1de8f7ca0e6b02e","predicate":"inhibits","confidence":0.9,"source_documents":["PMC12754786"],"created_at":"2026-01-23T04:23:35.798231+00:00","properties":{"evidence":"replication-dependent and PARP1/PARP2-mediated PARylation recruits the base excision repair (BER)/single-strand break repair (SSBR) scaffold protein XRCC1...","extraction_method":"llm"}}
{"subject_id":"prov:401d504013204ca4ae526c0e75d4d5bc","object_id":"prov:6d449d0e361346428b3b342e491987f5","predicate":"inhibits","confidence":0.9,"source_documents":["PMC12754786"],"created_at":"2026-01-23T04:23:35.798240+00:00","properties":{"evidence":"replication-dependent and PARP1/PARP2-mediated PARylation recruits the base excision repair (BER)/single-strand break repair (SSBR) scaffold protein XRCC1...","extraction_method":"llm"}}
{"subject_id":"prov:6e3f1131e38f40eb96c476e51dfec5ff","object_id":"prov:288c14ba7dc14bff91e005d38501abdb","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12754786"],"created_at":"2026-01-23T04:23:35.798262+00:00","properties":{"evidence":"replication-dependent and PARP1/PARP2-mediated PARylation recruits the base excision repair (BER)/single-strand break repair (SSBR) scaffold protein XRCC1...","extraction_method":"llm"}}
{"subject_id":"prov:6e3f1131e38f40eb96c476e51dfec5ff","object_id":"prov:1277178870244a20b7f6cea131aaf6d6","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12754786"],"created_at":"2026-01-23T04:23:35.798271+00:00","properties":{"evidence":"replication-dependent and PARP1/PARP2-mediated PARylation recruits the base excision repair (BER)/single-strand break repair (SSBR) scaffold protein XRCC1...","extraction_method":"llm"}}
{"subject_id":"prov:6e3f1131e38f40eb96c476e51dfec5ff","object_id":"prov:e2d85f3088cc49a19db3b47c6a32b96b","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12754786"],"created_at":"2026-01-23T04:23:35.798283+00:00","properties":{"evidence":"replication-dependent and PARP1/PARP2-mediated PARylation recruits the base excision repair (BER)/single-strand break repair (SSBR) scaffold protein XRCC1...","extraction_method":"llm"}}
{"subject_id":"prov:ebd9965d69db467aa1de8f7ca0e6b02e","object_id":"prov:04928b4b87504e6b9802924009173821","predicate":"treats","confidence":0.9,"source_documents":["PMC12754786"],"created_at":"2026-01-23T04:23:35.798291+00:00","properties":{"evidence":"loss of these proteins sensitizes glioblastoma and ovarian cancer cells to each.","extraction_method":"llm"}}
{"subject_id":"prov:ebd9965d69db467aa1de8f7ca0e6b02e","object_id":"prov:33aede1463c247dfa7ce2e6d85a5dd67","predicate":"treats","confidence":0.9,"source_documents":["PMC12754786"],"created_at":"2026-01-23T04:23:35.798299+00:00","properties":{"evidence":"loss of these proteins sensitizes glioblastoma and ovarian cancer cells to each.","extraction_method":"llm"}}
{"subject_id":"prov:6d449d0e361346428b3b342e491987f5","object_id":"prov:0145bf6c202e42a7af2ab9a040938348","predicate":"interacts_with","confidence":0.9,"source_documents":["PMC12754786"],"created_at":"2026-01-23T04:23:35.798309+00:00","properties":{"evidence":"enhanced PAR levels and PARG inhibitor-induced activation of the ATR/CHK1 S-phase checkpoint kinases","extraction_method":"llm"}}
{"subject_id":"prov:e5e59ff6f6fc4f4bb88daf5f48c37c20","object_id":"prov:606bc3374bcc4f3b9a90a33800cee79f","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12755470"],"created_at":"2026-01-23T04:23:42.246281+00:00","properties":{"evidence":"Increasing evidence has suggested a strong association of Q223R (rs1137101) and K109R (rs1137100) polymorphisms in leptin receptor (LEPR) gene with susceptibility of breast cancer (BC)","extraction_method":"llm"}}
{"subject_id":"prov:7892ff98c11b4d86b4a2afc5bb824972","object_id":"prov:606bc3374bcc4f3b9a90a33800cee79f","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12755470"],"created_at":"2026-01-23T04:23:42.246308+00:00","properties":{"evidence":"Increasing evidence has suggested a strong association of Q223R (rs1137101) and K109R (rs1137100) polymorphisms in leptin receptor (LEPR) gene with susceptibility of breast cancer (BC)","extraction_method":"llm"}}
{"subject_id":"prov:e5e59ff6f6fc4f4bb88daf5f48c37c20","object_id":"prov:606bc3374bcc4f3b9a90a33800cee79f","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12755470"],"created_at":"2026-01-23T04:23:42.246318+00:00","properties":{"evidence":"Significant association between Q223R polymorphism and BC risk was not found in total, Asian or Caucasian population, but in African population: allelic model, OR = 0.72, 95% CI = 0.60-0.86, p < 0.001; recessive model, OR = 0.67, 95%CI = 0.52-0.87, P = 0.003; dominant model, OR = 1.58, 95% CI = 1.15-2.17, p = 0.004; homozygous model, OR = 0.51, 95% CI = 0.36-0.78, p < 0.001.","extraction_method":"llm"}}
{"subject_id":"prov:7892ff98c11b4d86b4a2afc5bb824972","object_id":"prov:606bc3374bcc4f3b9a90a33800cee79f","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12755470"],"created_at":"2026-01-23T04:23:42.246326+00:00","properties":{"evidence":"Significant association between K109R polymorphism and BC risk was not found in total or Caucasian population, but in Asian population: dominant model, OR = 0.24, 95% CI = 0.07-0.84, p = 0.03; heterozygous model, OR = 1.87, 95% CI = 1.07-3.26, p = 0.03.","extraction_method":"llm"}}
{"subject_id":"prov:16d7477f94454035ab1e0e961e1ed03c","object_id":"prov:ac6e3a388de14fe4bae74b572d7b6407","predicate":"inhibits","confidence":0.8,"source_documents":["PMC12757100"],"created_at":"2026-01-23T04:23:47.673071+00:00","properties":{"evidence":"In this meta-analysis, we set out to evaluate the potential for using immune checkpoint inhibitors (ICIs), targeting either programmed cell death protein 1 (PD-1) or programmed cell death ligand 1 (PD-L1), in TNBC","extraction_method":"llm"}}
{"subject_id":"prov:48dc8dfeec0f4c05a46958fbc6c7ccb4","object_id":"prov:ac6e3a388de14fe4bae74b572d7b6407","predicate":"inhibits","confidence":0.8,"source_documents":["PMC12757100"],"created_at":"2026-01-23T04:23:47.673097+00:00","properties":{"evidence":"In this meta-analysis, we set out to evaluate the potential for using immune checkpoint inhibitors (ICIs), targeting either programmed cell death protein 1 (PD-1) or programmed cell death ligand 1 (PD-L1), in TNBC","extraction_method":"llm"}}
{"subject_id":"prov:a6d52dc454a14e77882c6f5fbbd954f5","object_id":"prov:e853c93d861540ebab6e11fa4fbf2e6c","predicate":"treats","confidence":0.9,"source_documents":["PMC12757276"],"created_at":"2026-01-23T04:23:50.949735+00:00","properties":{"evidence":"Utilizing a case of complete pathologic response to Lenvatinib","extraction_method":"llm"}}
{"subject_id":"prov:a6d52dc454a14e77882c6f5fbbd954f5","object_id":"prov:7ecf0935246e495ca7aef55ad36c453b","predicate":"treats","confidence":0.9,"source_documents":["PMC12757276"],"created_at":"2026-01-23T04:23:50.949754+00:00","properties":{"evidence":"Utilizing a case of complete pathologic response to Lenvatinib, pembrolizumab","extraction_method":"llm"}}
{"subject_id":"prov:a6d52dc454a14e77882c6f5fbbd954f5","object_id":"prov:d428d99f76c24241acc04fd903a838fb","predicate":"treats","confidence":0.9,"source_documents":["PMC12757276"],"created_at":"2026-01-23T04:23:50.949759+00:00","properties":{"evidence":"Utilizing a case of complete pathologic response to Lenvatinib, pembrolizumab, and spatially fractionated radiotherapy (SFRT)","extraction_method":"llm"}}
{"subject_id":"prov:e853c93d861540ebab6e11fa4fbf2e6c","object_id":"prov:7ecf0935246e495ca7aef55ad36c453b","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12757276"],"created_at":"2026-01-23T04:23:50.949764+00:00","properties":{"evidence":"Utilizing a case of complete pathologic response to Lenvatinib, pembrolizumab","extraction_method":"llm"}}
{"subject_id":"prov:e853c93d861540ebab6e11fa4fbf2e6c","object_id":"prov:d428d99f76c24241acc04fd903a838fb","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12757276"],"created_at":"2026-01-23T04:23:50.949768+00:00","properties":{"evidence":"Utilizing a case of complete pathologic response to Lenvatinib, pembrolizumab, and spatially fractionated radiotherapy (SFRT)","extraction_method":"llm"}}
{"subject_id":"prov:7ecf0935246e495ca7aef55ad36c453b","object_id":"prov:d428d99f76c24241acc04fd903a838fb","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12757276"],"created_at":"2026-01-23T04:23:50.949781+00:00","properties":{"evidence":"Utilizing a case of complete pathologic response to Lenvatinib, pembrolizumab, and spatially fractionated radiotherapy (SFRT)","extraction_method":"llm"}}
{"subject_id":"prov:a91a6998c33c40ad8661f8d680742158","object_id":"prov:aed48b4fd3714612b5097451399ea3df","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12757429"],"created_at":"2026-01-23T04:23:54.580332+00:00","properties":{"evidence":"PSMD14 was significantly overexpressed in LUAD tissues at both mRNA and protein levels","extraction_method":"llm"}}
{"subject_id":"prov:a91a6998c33c40ad8661f8d680742158","object_id":"prov:eb256454c69849fbad34f160548769af","predicate":"interacts_with","confidence":0.8,"source_documents":["PMC12757429"],"created_at":"2026-01-23T04:23:54.580363+00:00","properties":{"evidence":"Mechanistically, PSMD14 directly interacted with HMMR","extraction_method":"llm"}}
{"subject_id":"prov:4e6935414f544bfdb9ff27b1abe69858","object_id":"prov:a91a6998c33c40ad8661f8d680742158","predicate":"inhibits","confidence":0.9,"source_documents":["PMC12757429"],"created_at":"2026-01-23T04:23:54.580385+00:00","properties":{"evidence":"The PSMD14 inhibitor Capzimin exhibited potent anti-tumor effects in vitro and in vivo","extraction_method":"llm"}}
{"subject_id":"prov:b89d0b3bb83443749a7bdb649940b223","object_id":"prov:aed48b4fd3714612b5097451399ea3df","predicate":"treats","confidence":0.8,"source_documents":["PMC12757429"],"created_at":"2026-01-23T04:23:54.580396+00:00","properties":{"evidence":"combination therapy with the TGF-β inhibitor galunisertib demonstrated enhanced efficacy","extraction_method":"llm"}}
{"subject_id":"prov:3fedd0932d5f426ba375bdf3e5ff2995","object_id":"prov:02b4e0173f0448898efbb0657687d54a","predicate":"treats","confidence":0.9,"source_documents":["PMC12757875"],"created_at":"2026-01-23T04:24:01.226204+00:00","properties":{"evidence":"Despite the integration of PD-L1 inhibitors with chemotherapy, extensive-stage small-cell lung cancer (ES-SCLC) continues to portend a dismal prognosis...","extraction_method":"llm"}}
{"subject_id":"prov:3fedd0932d5f426ba375bdf3e5ff2995","object_id":"prov:21696e9d6da74613bb7eff21cfa0bead","predicate":"treats","confidence":0.9,"source_documents":["PMC12757875"],"created_at":"2026-01-23T04:24:01.226254+00:00","properties":{"evidence":"A critical unmet need is the lack of validated biomarkers to identify patients who may benefit from novel combinations of DNA damage repair (DDR) inhibitors and immune checkpoint blockers (ICB).","extraction_method":"llm"}}
{"subject_id":"prov:3fedd0932d5f426ba375bdf3e5ff2995","object_id":"prov:1921c4ec10c049b1bdc9fabaed60548e","predicate":"treats","confidence":0.9,"source_documents":["PMC12757875"],"created_at":"2026-01-23T04:24:01.226261+00:00","properties":{"evidence":"A critical unmet need is the lack of validated biomarkers to identify patients who may benefit from novel combinations of DNA damage repair (DDR) inhibitors and immune checkpoint blockers (ICB).","extraction_method":"llm"}}
{"subject_id":"prov:3fedd0932d5f426ba375bdf3e5ff2995","object_id":"prov:6342bb08911f411880f5ebad612b68b0","predicate":"treats","confidence":0.9,"source_documents":["PMC12757875"],"created_at":"2026-01-23T04:24:01.226280+00:00","properties":{"evidence":"Its predictive performance was validated in an independent cohort from the MSK-IMPACT study (n=152 ES-SCLC patients receiving PARP-ICB).","extraction_method":"llm"}}
{"subject_id":"prov:945c818fdcbe49878b5c9c4005312870","object_id":"prov:39f479b26ff84b1296a4485eb9e13419","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12758042"],"created_at":"2026-01-23T04:24:06.823246+00:00","properties":{"evidence":"Breast cancer remains the most common cancer globally, with approximately 5-15% of cases linked to pathogenic variants primarily in BRCA1 or BRCA2.","extraction_method":"llm"}}
{"subject_id":"prov:e0cdfec14e164d0c9263fd8033de47cf","object_id":"prov:39f479b26ff84b1296a4485eb9e13419","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12758042"],"created_at":"2026-01-23T04:24:06.823277+00:00","properties":{"evidence":"Breast cancer remains the most common cancer globally, with approximately 5-15% of cases linked to pathogenic variants primarily in BRCA1 or BRCA2.","extraction_method":"llm"}}
{"subject_id":"prov:e7d84f0c9de049ed8095b644ec855c4e","object_id":"prov:39f479b26ff84b1296a4485eb9e13419","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12758042"],"created_at":"2026-01-23T04:24:06.823287+00:00","properties":{"evidence":"Breast cancer remains the most common cancer globally, with approximately 5-15% of cases linked to pathogenic variants primarily in BRCA1 or BRCA2.","extraction_method":"llm"}}
{"subject_id":"prov:b4e68bc1eca24c999a502866552b1df7","object_id":"prov:9a566ea6b09c4939bf611c3e1cb96df9","predicate":"prevents","confidence":0.8,"source_documents":["PMC12758042"],"created_at":"2026-01-23T04:24:06.823296+00:00","properties":{"evidence":"Selective estrogen receptor modulators (SERMs) and aromatase inhibitors have shown potential as chemopreventive agents, but uptake remains limited due to concerns about efficacy and side effects.","extraction_method":"llm"}}
{"subject_id":"prov:74f6c78ce7ec413da57c72c25663dce5","object_id":"prov:9a566ea6b09c4939bf611c3e1cb96df9","predicate":"prevents","confidence":0.8,"source_documents":["PMC12758042"],"created_at":"2026-01-23T04:24:06.823305+00:00","properties":{"evidence":"Selective estrogen receptor modulators (SERMs) and aromatase inhibitors have shown potential as chemopreventive agents, but uptake remains limited due to concerns about efficacy and side effects.","extraction_method":"llm"}}
{"subject_id":"prov:93df743047cb4d44bc429e043b9890ee","object_id":"prov:9a566ea6b09c4939bf611c3e1cb96df9","predicate":"prevents","confidence":0.9,"source_documents":["PMC12758042"],"created_at":"2026-01-23T04:24:06.823315+00:00","properties":{"evidence":"Risk-reducing surgeries, such as bilateral salpingo-oophorectomy (BSO) and mastectomy, significantly lower the risk of breast and ovarian cancer;","extraction_method":"llm"}}
{"subject_id":"prov:945c818fdcbe49878b5c9c4005312870","object_id":"prov:e0cdfec14e164d0c9263fd8033de47cf","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12758042"],"created_at":"2026-01-23T04:24:06.823323+00:00","properties":{"evidence":"Breast cancer remains the most common cancer globally, with approximately 5-15% of cases linked to pathogenic variants primarily in BRCA1 or BRCA2.","extraction_method":"llm"}}
{"subject_id":"prov:945c818fdcbe49878b5c9c4005312870","object_id":"prov:e7d84f0c9de049ed8095b644ec855c4e","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12758042"],"created_at":"2026-01-23T04:24:06.823344+00:00","properties":{"evidence":"Breast cancer remains the most common cancer globally, with approximately 5-15% of cases linked to pathogenic variants primarily in BRCA1 or BRCA2.","extraction_method":"llm"}}
{"subject_id":"prov:7be82fd63a294a75b381958a8edda35b","object_id":"prov:2bb0f6f4b6df4ce9955b98072bec1907","predicate":"supports","confidence":0.9,"source_documents":["PMC12758147"],"created_at":"2026-01-23T04:24:08.840628+00:00","properties":{"evidence":"underlies tumor-intrinsic and tumor-extrinsic mechanisms that support cancer development and progression","extraction_method":"llm"}}
{"subject_id":"prov:b7af8b5935ff44d1a648f34161771951","object_id":"prov:2bb0f6f4b6df4ce9955b98072bec1907","predicate":"supports","confidence":0.9,"source_documents":["PMC12758147"],"created_at":"2026-01-23T04:24:08.840667+00:00","properties":{"evidence":"underlies tumor-intrinsic and tumor-extrinsic mechanisms that support cancer development and progression","extraction_method":"llm"}}
{"subject_id":"prov:96e6b482429a4736b323be6ef0921999","object_id":"prov:aef032106a204430be3503b3b0ce3e4b","predicate":"treats","confidence":0.9,"source_documents":["PMC12758711"],"created_at":"2026-01-23T04:24:11.778028+00:00","properties":{"evidence":"Pathologic complete response (pCR) to neoadjuvant chemotherapy (NACT) is a strong prognostic indicator in triple-negative breast cancer (TNBC).","extraction_method":"llm"}}
{"subject_id":"prov:28f7c126a89f463a86bd19e532b8b53b","object_id":"prov:9136132cfb7e43f88426d5e123a368e9","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12758711"],"created_at":"2026-01-23T04:24:11.778062+00:00","properties":{"evidence":"These genes may serve as predictive biomarkers for NAC response.","extraction_method":"llm"}}
{"subject_id":"prov:bd42bda4d9a64c70a8a4bd22f609c8c3","object_id":"prov:24373e85101f43649fac7be7c5f01663","predicate":"causes","confidence":0.9,"source_documents":["PMC12759042"],"created_at":"2026-01-23T04:24:15.424206+00:00","properties":{"evidence":"Most high‐grade serous ovarian cancer (HGSOC) cases arise from pre‐invasive fallopian tube (FT) lesions, known as serous tubal intraepithelial carcinomas (STICs).","extraction_method":"llm"}}
{"subject_id":"prov:79d3f939bf4b4b29abe0e9171aa80825","object_id":"prov:bd42bda4d9a64c70a8a4bd22f609c8c3","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12759042"],"created_at":"2026-01-23T04:24:15.424236+00:00","properties":{"evidence":"we collected 27 FT lavages from high‐risk BRCA1/2 mutation carriers, ovarian neoplasm (ON) patients, and control individuals with benign or non‐tubal gynaecological conditions","extraction_method":"llm"}}
{"subject_id":"prov:16bb2d47d8584d4ebdc076684a7022c1","object_id":"prov:bd42bda4d9a64c70a8a4bd22f609c8c3","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12759042"],"created_at":"2026-01-23T04:24:15.424248+00:00","properties":{"evidence":"we collected 27 FT lavages from high‐risk BRCA1/2 mutation carriers, ovarian neoplasm (ON) patients, and control individuals with benign or non‐tubal gynaecological conditions","extraction_method":"llm"}}
{"subject_id":"prov:ffdfb909c8d54225ab6fc6d84c7e25b0","object_id":"prov:3de6ff2c3fc342d8a7d236abc05b261d","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12764803"],"created_at":"2026-01-23T04:24:30.681887+00:00","properties":{"evidence":"BackgroundHomologous recombination deficiency (HRD) has emerged as a functional biomarker reflecting genome-wide DNA repair defects and genomic instability.","extraction_method":"llm"}}
{"subject_id":"prov:b5fefd4e03094446b996d3912f1033cb","object_id":"prov:5a5b836a0b2c46649db750934d2ff38c","predicate":"interacts_with","confidence":0.8,"source_documents":["PMC12764932"],"created_at":"2026-01-23T04:24:39.694534+00:00","properties":{"evidence":"Here, we highlight the complex interplay between KRAS signaling, the transcriptional coactivator YES1-associated protein (YAP) and Src family kinases (SFKs) in the pathogenesis of PDAC and drug sensitivity.","extraction_method":"llm"}}
{"subject_id":"prov:191099e2dcf54426906fa20b2c41ba64","object_id":"prov:5a5b836a0b2c46649db750934d2ff38c","predicate":"interacts_with","confidence":0.8,"source_documents":["PMC12764932"],"created_at":"2026-01-23T04:24:39.694563+00:00","properties":{"evidence":"Here, we highlight the complex interplay between KRAS signaling, the transcriptional coactivator YES1-associated protein (YAP) and Src family kinases (SFKs) in the pathogenesis of PDAC and drug sensitivity.","extraction_method":"llm"}}
{"subject_id":"prov:038192230a0a4f268f206c638217daa1","object_id":"prov:0770382c5d654548bd1dc893cc596a86","predicate":"inhibits","confidence":0.9,"source_documents":["PMC12765812"],"created_at":"2026-01-23T04:24:49.012028+00:00","properties":{"evidence":"Here, we identified betulinic acid (BA) as a potent inhibitor of FA pathway activation.","extraction_method":"llm"}}
{"subject_id":"prov:94b88905fab2450aa9bcc776f5cb21a4","object_id":"prov:748548ff20e04d3b8df93b291731e5d0","predicate":"causes","confidence":0.9,"source_documents":["PMC12765899"],"created_at":"2026-01-23T04:24:51.447897+00:00","properties":{"evidence":"We explore the dual role of mitophagy as both a disease driver and a therapeutic target, highlighting the efforts and challenges of translating mechanistic insights into precision therapies.","extraction_method":"llm"}}
{"subject_id":"prov:823823a20c2244b296e3c5d67487acf4","object_id":"prov:2c52349927b9435b805919174e576efb","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12766425"],"created_at":"2026-01-23T04:24:59.354020+00:00","properties":{"evidence":"Lynch syndrome (LS) is strongly associated with colorectal (CRC) and endometrial (EC) cancers,","extraction_method":"llm"}}
{"subject_id":"prov:823823a20c2244b296e3c5d67487acf4","object_id":"prov:804767807d324befa233c6e9e394d56f","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12766425"],"created_at":"2026-01-23T04:24:59.354041+00:00","properties":{"evidence":"Lynch syndrome (LS) is strongly associated with colorectal (CRC) and endometrial (EC) cancers,","extraction_method":"llm"}}
{"subject_id":"prov:e0a1cf8b0f3b48aaa06db7097f73b088","object_id":"prov:2c52349927b9435b805919174e576efb","predicate":"diagnosed_by","confidence":0.9,"source_documents":["PMC12766425"],"created_at":"2026-01-23T04:24:59.354048+00:00","properties":{"evidence":"Universal Tumor Screening (UTS) via mismatch repair proteins (MMRs) immunohistochemistry is currently recommended","extraction_method":"llm"}}
{"subject_id":"prov:823823a20c2244b296e3c5d67487acf4","object_id":"prov:7cce09a4eb634462b9f153528ff17a38","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12766425"],"created_at":"2026-01-23T04:24:59.354075+00:00","properties":{"evidence":"The highest SIRs were observed for cancers of the small intestine [SIR: 10.54; 95% CI: 5.90–17.39], urothelium/kidney [7.55; 95% CI: 5.42–10.24]","extraction_method":"llm"}}
{"subject_id":"prov:823823a20c2244b296e3c5d67487acf4","object_id":"prov:ecf7adc8670a400d9ae292934da90b36","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12766425"],"created_at":"2026-01-23T04:24:59.354057+00:00","properties":{"evidence":"The most common types were urothelial/kidney (8%), breast (8%), ovarian (6%) and gastric (4%) cancers.","extraction_method":"llm"}}
{"subject_id":"prov:823823a20c2244b296e3c5d67487acf4","object_id":"prov:e57a766f08524f8ab6452978d9c44784","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12766425"],"created_at":"2026-01-23T04:24:59.354062+00:00","properties":{"evidence":"The most common types were urothelial/kidney (8%), breast (8%), ovarian (6%) and gastric (4%) cancers.","extraction_method":"llm"}}
{"subject_id":"prov:823823a20c2244b296e3c5d67487acf4","object_id":"prov:c30754886a8c43d19b24ac4e5c100b44","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12766425"],"created_at":"2026-01-23T04:24:59.354067+00:00","properties":{"evidence":"The most common types were urothelial/kidney (8%), breast (8%), ovarian (6%) and gastric (4%) cancers.","extraction_method":"llm"}}
{"subject_id":"prov:823823a20c2244b296e3c5d67487acf4","object_id":"prov:d4e22ec4b6d54c1cb571a0c6e3cbd8b0","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12766425"],"created_at":"2026-01-23T04:24:59.354072+00:00","properties":{"evidence":"The highest SIRs were observed for cancers of the small intestine [SIR: 10.54; 95% CI: 5.90–17.39], urothelium/kidney [7.55; 95% CI: 5.42–10.24]","extraction_method":"llm"}}
{"subject_id":"prov:823823a20c2244b296e3c5d67487acf4","object_id":"prov:409c400a16774bbea79f819f13bf1e8a","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12766425"],"created_at":"2026-01-23T04:24:59.354080+00:00","properties":{"evidence":"The highest SIRs were observed for cancers of the small intestine [SIR: 10.54; 95% CI: 5.90–17.39], urothelium/kidney [7.55; 95% CI: 5.42–10.24]","extraction_method":"llm"}}
{"subject_id":"prov:c7ced8094a19408697aee84d58259d8c","object_id":"prov:a6ba7c05fbe54840a5d4383b9b6b3ba2","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12767394"],"created_at":"2026-01-23T04:25:03.655287+00:00","properties":{"evidence":"Increased levels of glutathione (GSH) and related antioxidant processes are thought to predict breast tumor aggressiveness and therapy response.","extraction_method":"llm"}}
{"subject_id":"prov:b0c17af0edd94d5d8dfd95f849171e8e","object_id":"prov:41b748ddf66940c6b25da825a4eed025","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12767500"],"created_at":"2026-01-23T04:25:11.745878+00:00","properties":{"evidence":"PVs in ATM, BRCA2, CHEK2, HOXB13, and PALB2 were presented in 4% of aggressive/metastatic PCa cases and were significantly associated with an increased risk of aggressive PCa (odds ratio 2.18–5.96, p < 0.05)","extraction_method":"llm"}}
{"subject_id":"prov:014dc963553b402b9ff5d8f96f9cb2ad","object_id":"prov:41b748ddf66940c6b25da825a4eed025","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12767500"],"created_at":"2026-01-23T04:25:11.745927+00:00","properties":{"evidence":"PVs in ATM, BRCA2, CHEK2, HOXB13, and PALB2 were presented in 4% of aggressive/metastatic PCa cases and were significantly associated with an increased risk of aggressive PCa (odds ratio 2.18–5.96, p < 0.05)","extraction_method":"llm"}}
{"subject_id":"prov:c6957bfa374645a2aff3e4e5b0d5a8a9","object_id":"prov:41b748ddf66940c6b25da825a4eed025","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12767500"],"created_at":"2026-01-23T04:25:11.745937+00:00","properties":{"evidence":"PVs in ATM, BRCA2, CHEK2, HOXB13, and PALB2 were presented in 4% of aggressive/metastatic PCa cases and were significantly associated with an increased risk of aggressive PCa (odds ratio 2.18–5.96, p < 0.05)","extraction_method":"llm"}}
{"subject_id":"prov:519df7a0cceb46648c313760e444a907","object_id":"prov:41b748ddf66940c6b25da825a4eed025","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12767500"],"created_at":"2026-01-23T04:25:11.745946+00:00","properties":{"evidence":"PVs in ATM, BRCA2, CHEK2, HOXB13, and PALB2 were presented in 4% of aggressive/metastatic PCa cases and were significantly associated with an increased risk of aggressive PCa (odds ratio 2.18–5.96, p < 0.05)","extraction_method":"llm"}}
{"subject_id":"prov:5e8c0c8114d34a63ad2a17a4ca2734b5","object_id":"prov:41b748ddf66940c6b25da825a4eed025","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12767500"],"created_at":"2026-01-23T04:25:11.745984+00:00","properties":{"evidence":"PVs in ATM, BRCA2, CHEK2, HOXB13, and PALB2 were presented in 4% of aggressive/metastatic PCa cases and were significantly associated with an increased risk of aggressive PCa (odds ratio 2.18–5.96, p < 0.05)","extraction_method":"llm"}}
{"subject_id":"prov:8cddc1a8434d4c6d8995439287d4db5a","object_id":"prov:41b748ddf66940c6b25da825a4eed025","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12767500"],"created_at":"2026-01-23T04:25:11.745989+00:00","properties":{"evidence":"PVs in ATM, BRCA2, CHEK2, HOXB13, and PALB2 were presented in 4% of aggressive/metastatic PCa cases and were significantly associated with an increased risk of aggressive PCa (odds ratio 2.18–5.96, p < 0.05)","extraction_method":"llm"}}
{"subject_id":"prov:b0c17af0edd94d5d8dfd95f849171e8e","object_id":"prov:7a9600d3799549dbbcb9b15a2220c884","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12767500"],"created_at":"2026-01-23T04:25:11.746000+00:00","properties":{"evidence":"We analyzed 7176 PCa cases and 4873 controls from seven countries across North America and Africa to assess the association between PVs in 37 cancer predisposition genes and the risk of overall, aggressive, and metastatic PCa.","extraction_method":"llm"}}
{"subject_id":"prov:07effcb3205d43f2a25eff031634670d","object_id":"prov:41b748ddf66940c6b25da825a4eed025","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12767500"],"created_at":"2026-01-23T04:25:11.746009+00:00","properties":{"evidence":"PV carriers with a positive family history and a PRS in the 90th percentile had seven, 18, and 34 times the risks of overall, aggressive, and metastatic PCa, respectively, compared with average-risk individuals.","extraction_method":"llm"}}
{"subject_id":"prov:f5d34c43bea64598826a41db5cec4fe6","object_id":"prov:1c25291a96ab474bb4c4cc01738b8dac","predicate":"treats","confidence":0.9,"source_documents":["PMC12768212"],"created_at":"2026-01-23T04:25:13.443191+00:00","properties":{"evidence":"AI-driven genomic tools, especially in the detection of fusion genes, enhance diagnostic sensitivity, speed, and accuracy","extraction_method":"llm"}}
{"subject_id":"prov:101d4a8528a346178934ebe215087948","object_id":"prov:adf11e5a60f74853a101148b73b026d1","predicate":"treats","confidence":0.9,"source_documents":["PMC12768587"],"created_at":"2026-01-23T04:25:17.069235+00:00","properties":{"evidence":"PurposeSurveillance guidelines following breast cancer surgery recommend mammography as the sole imaging modality.","extraction_method":"llm"}}
{"subject_id":"prov:4652f62a4531409fa93bfb4dd50c4f51","object_id":"prov:adf11e5a60f74853a101148b73b026d1","predicate":"treats","confidence":0.9,"source_documents":["PMC12768587"],"created_at":"2026-01-23T04:25:17.069266+00:00","properties":{"evidence":"Additional imaging modalities, such as ultrasonography and magnetic resonance imaging (MRI), may offer diagnostic benefits.","extraction_method":"llm"}}
{"subject_id":"prov:1d675df0332f4471a5a4385085367ad2","object_id":"prov:adf11e5a60f74853a101148b73b026d1","predicate":"treats","confidence":0.9,"source_documents":["PMC12768587"],"created_at":"2026-01-23T04:25:17.069281+00:00","properties":{"evidence":"Additional imaging modalities, such as ultrasonography and magnetic resonance imaging (MRI), may offer diagnostic benefits.","extraction_method":"llm"}}
{"subject_id":"prov:1d675df0332f4471a5a4385085367ad2","object_id":"prov:4652f62a4531409fa93bfb4dd50c4f51","predicate":"diagnosed_by","confidence":0.9,"source_documents":["PMC12768587"],"created_at":"2026-01-23T04:25:17.069298+00:00","properties":{"evidence":"Participants will undergo two annual breast screenings, each consisting of mammography, ultrasonography, and MRI.","extraction_method":"llm"}}
{"subject_id":"prov:919ffbe7d3664eb4ad3e5c03fa2d5e5a","object_id":"prov:76318c344e064ba1a962f8f2370ecc1e","predicate":"treats","confidence":0.9,"source_documents":["PMC12769638"],"created_at":"2026-01-23T04:25:21.687157+00:00","properties":{"evidence":"Boric acid-mediated boron neutron capture therapy (BA-BNCT) has emerged as a promising approach for liver cancer.","extraction_method":"llm"}}
{"subject_id":"prov:8b8c9244f8f8404782448bdb598e3117","object_id":"prov:a126c082c9184a969a49dd61b436e9d5","predicate":"inhibits","confidence":0.8,"source_documents":["PMC12769638"],"created_at":"2026-01-23T04:25:21.687196+00:00","properties":{"evidence":"We targeted the DNA homologous recombination repair (HRR) protein RAD51. Before neutron irradiation, a RAD51 inhibitor, B02, was administered to evaluate its sensitization effect on both HepG2 and the radioresistant HepG2R cells.","extraction_method":"llm"}}
{"subject_id":"prov:a126c082c9184a969a49dd61b436e9d5","object_id":"prov:8b8c9244f8f8404782448bdb598e3117","predicate":"inhibits","confidence":0.8,"source_documents":["PMC12769638"],"created_at":"2026-01-23T04:25:21.687206+00:00","properties":{"evidence":"We targeted the DNA homologous recombination repair (HRR) protein RAD51. Before neutron irradiation, a RAD51 inhibitor, B02, was administered to evaluate its sensitization effect on both HepG2 and the radioresistant HepG2R cells.","extraction_method":"llm"}}
{"subject_id":"prov:61525521027c4eb2bdbd743df675a692","object_id":"prov:1159711e98bd4566bc3e83eacb331853","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12769942"],"created_at":"2026-01-23T04:25:28.624173+00:00","properties":{"evidence":"Neuroendocrine carcinomas are associated with hereditary conditions such as Lynch syndrome;","extraction_method":"llm"}}
{"subject_id":"prov:759409d5529f4cdfaed988016fba204e","object_id":"prov:42ffcc6022de459eab62848876ff2b2a","predicate":"treats","confidence":0.9,"source_documents":["PMC12770061"],"created_at":"2026-01-23T04:25:30.856145+00:00","properties":{"evidence":"Recent genetic advances revealed several causative genes for polyposis and non-polyposis syndromes.","extraction_method":"llm"}}
{"subject_id":"prov:759409d5529f4cdfaed988016fba204e","object_id":"prov:bb4cdbb212964a459762dde273a045e8","predicate":"treats","confidence":0.9,"source_documents":["PMC12770061"],"created_at":"2026-01-23T04:25:30.856174+00:00","properties":{"evidence":"Recent genetic advances revealed several causative genes for polyposis and non-polyposis syndromes.","extraction_method":"llm"}}
{"subject_id":"prov:dac3f2902d16491f86d16c6271e05e26","object_id":"prov:c52715ae5dc049948c52482bccd77aa8","predicate":"associated_with","confidence":0.7,"source_documents":["PMC12770061"],"created_at":"2026-01-23T04:25:30.856185+00:00","properties":{"evidence":"These guidelines provide an up-to-date summary of HCRC, along with clinical recommendations for managing FAP and Lynch syndrome.","extraction_method":"llm"}}
{"subject_id":"prov:1634af59316642d489bf308f86f835a8","object_id":"prov:c7239a1741e2450c82af2d2f8a6cfe46","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035381+00:00","properties":{"evidence":"Albumin-based nanoplatforms have emerged as promising solutions to address these therapeutic challenges by exploiting the inherent biocompatibility, biodegradability, extended circulation half-life, and natural tumor-targeting properties of albumin through interactions with gp60 and SPARC receptors that are overexpressed in TNBC tissues.","extraction_method":"llm"}}
{"subject_id":"prov:1634af59316642d489bf308f86f835a8","object_id":"prov:5b189e94000245efae691cb9ca2f366a","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035404+00:00","properties":{"evidence":"Albumin-based nanoplatforms have emerged as promising solutions to address these therapeutic challenges by exploiting the inherent biocompatibility, biodegradability, extended circulation half-life, and natural tumor-targeting properties of albumin through interactions with gp60 and SPARC receptors that are overexpressed in TNBC tissues.","extraction_method":"llm"}}
{"subject_id":"prov:1634af59316642d489bf308f86f835a8","object_id":"prov:c40288d76cf54e929be723f6db24dcb8","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035410+00:00","properties":{"evidence":"This comprehensive review examines the molecular design principles, fabrication strategies, and targeting mechanisms of albumin nanocarriers, including passive targeting via the enhanced permeability and retention (EPR) effect and active targeting through receptor‒ligand interactions with uPAR, EGFR, CD44, CXCR4, and folate receptors.","extraction_method":"llm"}}
{"subject_id":"prov:1634af59316642d489bf308f86f835a8","object_id":"prov:7f19ee16714140c399deeefa7e1cb2f4","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035415+00:00","properties":{"evidence":"This comprehensive review examines the molecular design principles, fabrication strategies, and targeting mechanisms of albumin nanocarriers, including passive targeting via the enhanced permeability and retention (EPR) effect and active targeting through receptor‒ligand interactions with uPAR, EGFR, CD44, CXCR4, and folate receptors.","extraction_method":"llm"}}
{"subject_id":"prov:1634af59316642d489bf308f86f835a8","object_id":"prov:915b5d30928a4708907a2aaf21c0b75b","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035419+00:00","properties":{"evidence":"This comprehensive review examines the molecular design principles, fabrication strategies, and targeting mechanisms of albumin nanocarriers, including passive targeting via the enhanced permeability and retention (EPR) effect and active targeting through receptor‒ligand interactions with uPAR, EGFR, CD44, CXCR4, and folate receptors.","extraction_method":"llm"}}
{"subject_id":"prov:1634af59316642d489bf308f86f835a8","object_id":"prov:0ffa59bd1cdc48dd98f21b8d8f43e1c2","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035423+00:00","properties":{"evidence":"This comprehensive review examines the molecular design principles, fabrication strategies, and targeting mechanisms of albumin nanocarriers, including passive targeting via the enhanced permeability and retention (EPR) effect and active targeting through receptor‒ligand interactions with uPAR, EGFR, CD44, CXCR4, and folate receptors.","extraction_method":"llm"}}
{"subject_id":"prov:1634af59316642d489bf308f86f835a8","object_id":"prov:0b35218686584b9c92bced4ccff994c9","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035427+00:00","properties":{"evidence":"This comprehensive review examines the molecular design principles, fabrication strategies, and targeting mechanisms of albumin nanocarriers, including passive targeting via the enhanced permeability and retention (EPR) effect and active targeting through receptor‒ligand interactions with uPAR, EGFR, CD44, CXCR4, and folate receptors.","extraction_method":"llm"}}
{"subject_id":"prov:7723eb6460254562b30caef85c00406c","object_id":"prov:c7239a1741e2450c82af2d2f8a6cfe46","predicate":"interacts_with","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035440+00:00","properties":{"evidence":"Albumin-based nanoplatforms have emerged as promising solutions to address these therapeutic challenges by exploiting the inherent biocompatibility, biodegradability, extended circulation half-life, and natural tumor-targeting properties of albumin through interactions with gp60 and SPARC receptors that are overexpressed in TNBC tissues.","extraction_method":"llm"}}
{"subject_id":"prov:7723eb6460254562b30caef85c00406c","object_id":"prov:5b189e94000245efae691cb9ca2f366a","predicate":"interacts_with","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035444+00:00","properties":{"evidence":"Albumin-based nanoplatforms have emerged as promising solutions to address these therapeutic challenges by exploiting the inherent biocompatibility, biodegradability, extended circulation half-life, and natural tumor-targeting properties of albumin through interactions with gp60 and SPARC receptors that are overexpressed in TNBC tissues.","extraction_method":"llm"}}
{"subject_id":"prov:7723eb6460254562b30caef85c00406c","object_id":"prov:c40288d76cf54e929be723f6db24dcb8","predicate":"interacts_with","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035448+00:00","properties":{"evidence":"This comprehensive review examines the molecular design principles, fabrication strategies, and targeting mechanisms of albumin nanocarriers, including passive targeting via the enhanced permeability and retention (EPR) effect and active targeting through receptor‒ligand interactions with uPAR, EGFR, CD44, CXCR4, and folate receptors.","extraction_method":"llm"}}
{"subject_id":"prov:7723eb6460254562b30caef85c00406c","object_id":"prov:7f19ee16714140c399deeefa7e1cb2f4","predicate":"interacts_with","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035452+00:00","properties":{"evidence":"This comprehensive review examines the molecular design principles, fabrication strategies, and targeting mechanisms of albumin nanocarriers, including passive targeting via the enhanced permeability and retention (EPR) effect and active targeting through receptor‒ligand interactions with uPAR, EGFR, CD44, CXCR4, and folate receptors.","extraction_method":"llm"}}
{"subject_id":"prov:7723eb6460254562b30caef85c00406c","object_id":"prov:915b5d30928a4708907a2aaf21c0b75b","predicate":"interacts_with","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035456+00:00","properties":{"evidence":"This comprehensive review examines the molecular design principles, fabrication strategies, and targeting mechanisms of albumin nanocarriers, including passive targeting via the enhanced permeability and retention (EPR) effect and active targeting through receptor‒ligand interactions with uPAR, EGFR, CD44, CXCR4, and folate receptors.","extraction_method":"llm"}}
{"subject_id":"prov:7723eb6460254562b30caef85c00406c","object_id":"prov:0ffa59bd1cdc48dd98f21b8d8f43e1c2","predicate":"interacts_with","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035459+00:00","properties":{"evidence":"This comprehensive review examines the molecular design principles, fabrication strategies, and targeting mechanisms of albumin nanocarriers, including passive targeting via the enhanced permeability and retention (EPR) effect and active targeting through receptor‒ligand interactions with uPAR, EGFR, CD44, CXCR4, and folate receptors.","extraction_method":"llm"}}
{"subject_id":"prov:7723eb6460254562b30caef85c00406c","object_id":"prov:0b35218686584b9c92bced4ccff994c9","predicate":"interacts_with","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035463+00:00","properties":{"evidence":"This comprehensive review examines the molecular design principles, fabrication strategies, and targeting mechanisms of albumin nanocarriers, including passive targeting via the enhanced permeability and retention (EPR) effect and active targeting through receptor‒ligand interactions with uPAR, EGFR, CD44, CXCR4, and folate receptors.","extraction_method":"llm"}}
{"subject_id":"prov:9c63ff435b1f47be9835d4a0357804f2","object_id":"prov:1634af59316642d489bf308f86f835a8","predicate":"treats","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035468+00:00","properties":{"evidence":"We analyze diverse therapeutic payloads, including conventional chemotherapeutics (paclitaxel, doxorubicin, and docetaxel), natural products (curcumin and resveratrol), and molecular therapeutics (siRNAs and CRISPR/Cas9) delivered via albumin nanoplatforms.","extraction_method":"llm"}}
{"subject_id":"prov:3a2272e647fd4ddeb605ed36c205265f","object_id":"prov:1634af59316642d489bf308f86f835a8","predicate":"treats","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035473+00:00","properties":{"evidence":"We analyze diverse therapeutic payloads, including conventional chemotherapeutics (paclitaxel, doxorubicin, and docetaxel), natural products (curcumin and resveratrol), and molecular therapeutics (siRNAs and CRISPR/Cas9) delivered via albumin nanoplatforms.","extraction_method":"llm"}}
{"subject_id":"prov:9d85023a79e54b8b96e13770a9ae1722","object_id":"prov:1634af59316642d489bf308f86f835a8","predicate":"treats","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035485+00:00","properties":{"evidence":"We analyze diverse therapeutic payloads, including conventional chemotherapeutics (paclitaxel, doxorubicin, and docetaxel), natural products (curcumin and resveratrol), and molecular therapeutics (siRNAs and CRISPR/Cas9) delivered via albumin nanoplatforms.","extraction_method":"llm"}}
{"subject_id":"prov:53f1bf0baa1f4f9192a6373bfc2b3082","object_id":"prov:1634af59316642d489bf308f86f835a8","predicate":"treats","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035489+00:00","properties":{"evidence":"We analyze diverse therapeutic payloads, including conventional chemotherapeutics (paclitaxel, doxorubicin, and docetaxel), natural products (curcumin and resveratrol), and molecular therapeutics (siRNAs and CRISPR/Cas9) delivered via albumin nanoplatforms.","extraction_method":"llm"}}
{"subject_id":"prov:3b6e11da0cc64ca5bf6d200a3b4a64a5","object_id":"prov:1634af59316642d489bf308f86f835a8","predicate":"treats","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035494+00:00","properties":{"evidence":"We analyze diverse therapeutic payloads, including conventional chemotherapeutics (paclitaxel, doxorubicin, and docetaxel), natural products (curcumin and resveratrol), and molecular therapeutics (siRNAs and CRISPR/Cas9) delivered via albumin nanoplatforms.","extraction_method":"llm"}}
{"subject_id":"prov:6b5106450cda424ea81d2d5e67a1c9b4","object_id":"prov:1634af59316642d489bf308f86f835a8","predicate":"treats","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035501+00:00","properties":{"evidence":"We analyze diverse therapeutic payloads, including conventional chemotherapeutics (paclitaxel, doxorubicin, and docetaxel), natural products (curcumin and resveratrol), and molecular therapeutics (siRNAs and CRISPR/Cas9) delivered via albumin nanoplatforms.","extraction_method":"llm"}}
{"subject_id":"prov:ba5677b770564d2bb50712e088508a6a","object_id":"prov:1634af59316642d489bf308f86f835a8","predicate":"treats","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035505+00:00","properties":{"evidence":"We analyze diverse therapeutic payloads, including conventional chemotherapeutics (paclitaxel, doxorubicin, and docetaxel), natural products (curcumin and resveratrol), and molecular therapeutics (siRNAs and CRISPR/Cas9) delivered via albumin nanoplatforms.","extraction_method":"llm"}}
{"subject_id":"prov:a0a2ae5aeba74a009f2d483431104143","object_id":"prov:1634af59316642d489bf308f86f835a8","predicate":"treats","confidence":0.9,"source_documents":["PMC12770113"],"created_at":"2026-01-23T04:25:49.035510+00:00","properties":{"evidence":"The clinical evidence supporting nab-paclitaxel in combination with immune checkpoint inhibitors has demonstrated significant improvements in progression-free survival and objective response rates in PD-L1-positive mTNBC patients.","extraction_method":"llm"}}
{"subject_id":"prov:70267096b21e4ef2baef7f8bee067194","object_id":"prov:e5f3230662614dd18c07c5608b1d173f","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12771675"],"created_at":"2026-01-23T04:25:51.271392+00:00","properties":{"evidence":"Resulting probabilities were used to evaluate ML penetrance of 1,648 rare variants in 31 autosomal dominant disease-predisposition genes.","extraction_method":"llm"}}
{"subject_id":"prov:6fed131c2e1a454e825f55c44de19ae4","object_id":"prov:e5f3230662614dd18c07c5608b1d173f","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12771675"],"created_at":"2026-01-23T04:25:51.271415+00:00","properties":{"evidence":"Resulting probabilities were used to evaluate ML penetrance of 1,648 rare variants in 31 autosomal dominant disease-predisposition genes.","extraction_method":"llm"}}
{"subject_id":"prov:70267096b21e4ef2baef7f8bee067194","object_id":"prov:6e9509a99b4c40aa9b94cb2f3c32bb18","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12771675"],"created_at":"2026-01-23T04:25:51.271421+00:00","properties":{"evidence":"ML penetrance was variable across variant classes but highest for pathogenic and loss-of-function variants,","extraction_method":"llm"}}
{"subject_id":"prov:6fed131c2e1a454e825f55c44de19ae4","object_id":"prov:6e9509a99b4c40aa9b94cb2f3c32bb18","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12771675"],"created_at":"2026-01-23T04:25:51.271425+00:00","properties":{"evidence":"ML penetrance was variable across variant classes but highest for pathogenic and loss-of-function variants,","extraction_method":"llm"}}
{"subject_id":"prov:48daa4a6515c4612a2899a716e20ff4f","object_id":"prov:a7478fcaa98d44249b58596c50e6a883","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12772505"],"created_at":"2026-01-23T04:25:52.943958+00:00","properties":{"evidence":"Breast fibroadenoma coexisting with ductal carcinoma in situ (DCIS) is clinically rare","extraction_method":"llm"}}
{"subject_id":"prov:612184c870ba4791ac1c141c7f5d1d6a","object_id":"prov:a7478fcaa98d44249b58596c50e6a883","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12772505"],"created_at":"2026-01-23T04:25:52.943986+00:00","properties":{"evidence":"Postoperative pathological examination revealed coexisting bilateral mammary fibroadenomas with DCIS","extraction_method":"llm"}}
{"subject_id":"prov:f09a1b691bdf478291fa84f47d2f2205","object_id":"prov:c38e7a6e8aa34d1bbed9d6086ba1b8df","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12772651"],"created_at":"2026-01-23T04:26:14.927473+00:00","properties":{"evidence":"We identify significant enrichment (false discovery rate (FDR)-adjusted P < 0.05) of predicted loss-of-function (pLoF) variants in COPB2 and GORAB among individuals misaligned for lower-than-expected bone mineral density.","extraction_method":"llm"}}
{"subject_id":"prov:93044e6adbf64bd68ac88b580957d66c","object_id":"prov:c38e7a6e8aa34d1bbed9d6086ba1b8df","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12772651"],"created_at":"2026-01-23T04:26:14.927516+00:00","properties":{"evidence":"We identify significant enrichment (false discovery rate (FDR)-adjusted P < 0.05) of predicted loss-of-function (pLoF) variants in COPB2 and GORAB among individuals misaligned for lower-than-expected bone mineral density.","extraction_method":"llm"}}
{"subject_id":"prov:158c287078624de68b98b87caf64d288","object_id":"prov:10eea9e8824d4c2782a18d3ee39f1f12","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12772651"],"created_at":"2026-01-23T04:26:14.927526+00:00","properties":{"evidence":"We refine previously observed grouped-gene enrichment in individuals with misaligned stature to the single-gene level: shorter-than-expected individuals are enriched for pLoF variants in ACAN and IGF1, and taller-than-expected individuals are enriched for predicted damaging missense in FBN1.","extraction_method":"llm"}}
{"subject_id":"prov:46beef8c52294865b5c2db2c13bdd252","object_id":"prov:10eea9e8824d4c2782a18d3ee39f1f12","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12772651"],"created_at":"2026-01-23T04:26:14.927534+00:00","properties":{"evidence":"We refine previously observed grouped-gene enrichment in individuals with misaligned stature to the single-gene level: shorter-than-expected individuals are enriched for pLoF variants in ACAN and IGF1, and taller-than-expected individuals are enriched for predicted damaging missense in FBN1.","extraction_method":"llm"}}
{"subject_id":"prov:008bbbcc513c48a59471e6af0d5f4fa4","object_id":"prov:10eea9e8824d4c2782a18d3ee39f1f12","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12772651"],"created_at":"2026-01-23T04:26:14.927541+00:00","properties":{"evidence":"We refine previously observed grouped-gene enrichment in individuals with misaligned stature to the single-gene level: shorter-than-expected individuals are enriched for pLoF variants in ACAN and IGF1, and taller-than-expected individuals are enriched for predicted damaging missense in FBN1.","extraction_method":"llm"}}
{"subject_id":"prov:0d4fd1397cee4126b83e8ab325458032","object_id":"prov:c38e7a6e8aa34d1bbed9d6086ba1b8df","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12772651"],"created_at":"2026-01-23T04:26:14.927550+00:00","properties":{"evidence":"Among individuals diagnosed with type 2 diabetes, carriers of rare pathogenic pLoF variants in HNF1A and HNF4A had significantly lower polygenic risk than non-carriers (FDR-adjusted one-sided t-test P < 5 × 10−3).","extraction_method":"llm"}}
{"subject_id":"prov:e7d28a807cf5451d822096576f1b2620","object_id":"prov:c38e7a6e8aa34d1bbed9d6086ba1b8df","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12772651"],"created_at":"2026-01-23T04:26:14.927571+00:00","properties":{"evidence":"Among individuals diagnosed with type 2 diabetes, carriers of rare pathogenic pLoF variants in HNF1A and HNF4A had significantly lower polygenic risk than non-carriers (FDR-adjusted one-sided t-test P < 5 × 10−3).","extraction_method":"llm"}}
{"subject_id":"prov:cf36e6e3b53b44dda15329bb6e959820","object_id":"prov:10eea9e8824d4c2782a18d3ee39f1f12","predicate":"prevents","confidence":0.9,"source_documents":["PMC12772651"],"created_at":"2026-01-23T04:26:14.927579+00:00","properties":{"evidence":"We also show that coronary artery disease controls carrying rare protective pLoF variants in ANGPTL3 had nominally higher polygenic risk than non-carriers.","extraction_method":"llm"}}
{"subject_id":"prov:7d5a1a20b1c5475189316ba7920ea056","object_id":"prov:aa844d2c2faa4bbd83791cb067cca687","predicate":"associated_with","confidence":0.8,"source_documents":["PMC12774523"],"created_at":"2026-01-23T04:26:20.762356+00:00","properties":{"evidence":"studies suggest a potential bidirectional association","extraction_method":"llm"}}
{"subject_id":"prov:a11f4c5986aa4e6fbe0b248e14a0d37b","object_id":"prov:7d5a1a20b1c5475189316ba7920ea056","predicate":"diagnosed_by","confidence":0.9,"source_documents":["PMC12774523"],"created_at":"2026-01-23T04:26:20.762384+00:00","properties":{"evidence":"While fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) is a valuable imaging modality for evaluating breast cancer","extraction_method":"llm"}}
{"subject_id":"prov:a11f4c5986aa4e6fbe0b248e14a0d37b","object_id":"prov:45529a8d3573430c97fad7dcb189ac8d","predicate":"diagnosed_by","confidence":0.8,"source_documents":["PMC12774523"],"created_at":"2026-01-23T04:26:20.762392+00:00","properties":{"evidence":"incidental FDG-avid thyroid lesions require further evaluation due to their potential malignancy risk","extraction_method":"llm"}}
{"subject_id":"prov:7d5a1a20b1c5475189316ba7920ea056","object_id":"prov:45529a8d3573430c97fad7dcb189ac8d","predicate":"increases_risk","confidence":0.7,"source_documents":["PMC12774523"],"created_at":"2026-01-23T04:26:20.762399+00:00","properties":{"evidence":"raising suspicion for malignancy","extraction_method":"llm"}}
{"subject_id":"prov:d172007971e141f9a4b714fdbd2d845d","object_id":"prov:b9214edf7f9d4bf58fa330dc401b988f","predicate":"interacts_with","confidence":0.9,"source_documents":["PMC12774643"],"created_at":"2026-01-23T04:26:27.194397+00:00","properties":{"evidence":"Here, we show that Lamin A/C modulates the epithelial–mesenchymal (E-M) plasticity of cells through its interaction with the chromatin organizer, EZH2.","extraction_method":"llm"}}
{"subject_id":"prov:67d9e6026e824cea84085634dfd093bf","object_id":"prov:01f6567156d44266b1b06ff1faf259dc","predicate":"interacts_with","confidence":0.9,"source_documents":["PMC12774752"],"created_at":"2026-01-23T04:26:32.954747+00:00","properties":{"evidence":"Elevated levels of eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) influence cap-independent translation by forming a complex with eukaryotic initiation factor 4E (eIF4E)","extraction_method":"llm"}}
{"subject_id":"prov:39c93fd7830048fe83234b9a0a2bd4e0","object_id":"prov:8dc3715e1d0f43049e5a1b30668c43d6","predicate":"interacts_with","confidence":0.9,"source_documents":["PMC12774752"],"created_at":"2026-01-23T04:26:32.954770+00:00","properties":{"evidence":"Importantly, eIF4GI557-1599 and its binding partner eIF4A, overcomes this inhibition selectively for CITE-like mRNAs,","extraction_method":"llm"}}
{"subject_id":"prov:a1f2978d990f45e7be39f86b40311827","object_id":"prov:d4794872251d431ba0322e6e266df3d2","predicate":"causes","confidence":0.9,"source_documents":["PMC12774997"],"created_at":"2026-01-23T04:26:37.046070+00:00","properties":{"evidence":"Up to 30% of women with no evidence of disease after curative intent breast cancer treatment will relapse and succumb to metastatic disease.","extraction_method":"llm"}}
{"subject_id":"prov:224c181c315f49e5b700aef22b1a8993","object_id":"prov:6b8d56003e8a45279cceba2b9f3ea2cb","predicate":"treats","confidence":0.9,"source_documents":["PMC12775167"],"created_at":"2026-01-23T04:26:43.086135+00:00","properties":{"evidence":"Treatment principles for MBC mirror those of female breast cancer and include mastectomy, endocrine therapy (tamoxifen), radiotherapy, and systemic therapy as indicated.","extraction_method":"llm"}}
{"subject_id":"prov:fbb263dfe8aa4045881df3d7ead76815","object_id":"prov:af34d2ae5f1b43f78a99c458d77cdb7b","predicate":"increases_risk","confidence":0.8,"source_documents":["PMC12775167"],"created_at":"2026-01-23T04:26:43.086155+00:00","properties":{"evidence":"The differential diagnosis of EPC in men includes gynecomastia, benign papillary lesions, solid papillary carcinoma, invasive papillary carcinoma, and metastases from prostate, thyroid, or gastrointestinal carcinomas.","extraction_method":"llm"}}
{"subject_id":"prov:fbb263dfe8aa4045881df3d7ead76815","object_id":"prov:14fe4dee496e4d3eb9422303435de867","predicate":"increases_risk","confidence":0.8,"source_documents":["PMC12775167"],"created_at":"2026-01-23T04:26:43.086161+00:00","properties":{"evidence":"The differential diagnosis of EPC in men includes gynecomastia, benign papillary lesions, solid papillary carcinoma, invasive papillary carcinoma, and metastases from prostate, thyroid, or gastrointestinal carcinomas.","extraction_method":"llm"}}
{"subject_id":"prov:fbb263dfe8aa4045881df3d7ead76815","object_id":"prov:6a3875f8538d40b2b5f5b744de74cff3","predicate":"increases_risk","confidence":0.8,"source_documents":["PMC12775167"],"created_at":"2026-01-23T04:26:43.086165+00:00","properties":{"evidence":"The differential diagnosis of EPC in men includes gynecomastia, benign papillary lesions, solid papillary carcinoma, invasive papillary carcinoma, and metastases from prostate, thyroid, or gastrointestinal carcinomas.","extraction_method":"llm"}}
{"subject_id":"prov:b4c8ef108cdd47e78447c12ac81aebe4","object_id":"prov:224c181c315f49e5b700aef22b1a8993","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12775167"],"created_at":"2026-01-23T04:26:43.086173+00:00","properties":{"evidence":"The tumor was estrogen receptor (ER)-positive...","extraction_method":"llm"}}
{"subject_id":"prov:6189288f7677462097ab7a8be9337015","object_id":"prov:224c181c315f49e5b700aef22b1a8993","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12775167"],"created_at":"2026-01-23T04:26:43.086177+00:00","properties":{"evidence":"The tumor was progesterone receptor (PR)-positive...","extraction_method":"llm"}}
{"subject_id":"prov:51bbbf9dd6f24080a650ec6f9d339b6c","object_id":"prov:224c181c315f49e5b700aef22b1a8993","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12775167"],"created_at":"2026-01-23T04:26:43.086189+00:00","properties":{"evidence":"The tumor was human epidermal growth factor receptor 2 (HER2)-low...","extraction_method":"llm"}}
{"subject_id":"prov:fc93439a618d4bc3ab0f4d8864d89c1b","object_id":"prov:c82b6dc595e04b4cbb67f6744f09d722","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12775414"],"created_at":"2026-01-23T04:26:47.902542+00:00","properties":{"evidence":"However, conventional gene selection techniques struggle to identify optimal biomarker subsets from gene data within a feasible time.","extraction_method":"llm"}}
{"subject_id":"prov:b57f0e99543a4c2993039207721dd433","object_id":"prov:ff4a34adb74c48f39954c019b5d64b6a","predicate":"treats","confidence":0.9,"source_documents":["PMC12775561"],"created_at":"2026-01-23T04:26:54.044046+00:00","properties":{"evidence":"The dual test showed a trend toward higher rates of genotype‐matched therapy (4.3% vs. 2.6%, p = 0.25) and a significantly higher rate of molecular targeted therapy (4.3% vs. 1.5%, p = 0.03)","extraction_method":"llm"}}
{"subject_id":"prov:b57f0e99543a4c2993039207721dd433","object_id":"prov:b07e8eaeb7c441b3a264f25f40998546","predicate":"treats","confidence":0.9,"source_documents":["PMC12775561"],"created_at":"2026-01-23T04:26:54.044091+00:00","properties":{"evidence":"The dual test showed a trend toward higher rates of genotype‐matched therapy (4.3% vs. 2.6%, p = 0.25) and a significantly higher rate of molecular targeted therapy (4.3% vs. 1.5%, p = 0.03)","extraction_method":"llm"}}
{"subject_id":"prov:ff4a34adb74c48f39954c019b5d64b6a","object_id":"prov:b57f0e99543a4c2993039207721dd433","predicate":"treats","confidence":0.9,"source_documents":["PMC12775561"],"created_at":"2026-01-23T04:26:54.044102+00:00","properties":{"evidence":"The dual test showed a trend toward higher rates of genotype‐matched therapy (4.3% vs. 2.6%, p = 0.25) and a significantly higher rate of molecular targeted therapy (4.3% vs. 1.5%, p = 0.03)","extraction_method":"llm"}}
{"subject_id":"prov:b07e8eaeb7c441b3a264f25f40998546","object_id":"prov:b57f0e99543a4c2993039207721dd433","predicate":"treats","confidence":0.9,"source_documents":["PMC12775561"],"created_at":"2026-01-23T04:26:54.044111+00:00","properties":{"evidence":"The dual test showed a trend toward higher rates of genotype‐matched therapy (4.3% vs. 2.6%, p = 0.25) and a significantly higher rate of molecular targeted therapy (4.3% vs. 1.5%, p = 0.03)","extraction_method":"llm"}}
{"subject_id":"prov:b07e8eaeb7c441b3a264f25f40998546","object_id":"prov:789e9a9e4bba4ba8b5885f33c7047cb1","predicate":"diagnosed_by","confidence":0.9,"source_documents":["PMC12775561"],"created_at":"2026-01-23T04:26:54.044120+00:00","properties":{"evidence":"Among patients with translocation‐related sarcomas, histology‐specific fusion genes were identified in 77.5% using the dual panel, compared to 40.0% with the DNA‐only panel (p < 0.001)","extraction_method":"llm"}}
{"subject_id":"prov:b07e8eaeb7c441b3a264f25f40998546","object_id":"prov:3820759b75bb4626bfc018f95c7279f7","predicate":"diagnosed_by","confidence":0.9,"source_documents":["PMC12775561"],"created_at":"2026-01-23T04:26:54.044129+00:00","properties":{"evidence":"The dual DNA–RNA test identified significantly more fusion genes (20.3% vs. 7.4%, p < 0.001) and therapeutically targetable kinase fusions (3.5% vs. 1.2%, p = .019)","extraction_method":"llm"}}
{"subject_id":"prov:789e9a9e4bba4ba8b5885f33c7047cb1","object_id":"prov:b57f0e99543a4c2993039207721dd433","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12775561"],"created_at":"2026-01-23T04:26:54.044175+00:00","properties":{"evidence":"Among patients with translocation‐related sarcomas, histology‐specific fusion genes were identified in 77.5% using the dual panel, compared to 40.0% with the DNA‐only panel (p < 0.001)","extraction_method":"llm"}}
{"subject_id":"prov:3820759b75bb4626bfc018f95c7279f7","object_id":"prov:b57f0e99543a4c2993039207721dd433","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12775561"],"created_at":"2026-01-23T04:26:54.044190+00:00","properties":{"evidence":"The dual DNA–RNA test identified significantly more fusion genes (20.3% vs. 7.4%, p < 0.001) and therapeutically targetable kinase fusions (3.5% vs. 1.2%, p = .019)","extraction_method":"llm"}}
{"subject_id":"prov:924d3adce9f1416186db5a6852571ed0","object_id":"prov:38b1a55762604f4f8928dca4626762ee","predicate":"causes","confidence":0.9,"source_documents":["PMC12775696"],"created_at":"2026-01-23T04:27:01.354308+00:00","properties":{"evidence":"Lung cancer represents one of the most prevalent malignant tumors and the leading cause of mortality from neoplastic diseases worldwide.","extraction_method":"llm"}}
{"subject_id":"prov:924d3adce9f1416186db5a6852571ed0","object_id":"prov:22c2148c52064a15971a6b499c598eae","predicate":"treats","confidence":0.8,"source_documents":["PMC12775696"],"created_at":"2026-01-23T04:27:01.354330+00:00","properties":{"evidence":"Despite significant advancements of lung cancer treatment in recent years, thanks to advancements in technologies such as chemotherapy...","extraction_method":"llm"}}
{"subject_id":"prov:924d3adce9f1416186db5a6852571ed0","object_id":"prov:762911736f1f4787afcfc8ab8fa79b0a","predicate":"treats","confidence":0.8,"source_documents":["PMC12775696"],"created_at":"2026-01-23T04:27:01.354336+00:00","properties":{"evidence":"Despite significant advancements of lung cancer treatment in recent years, thanks to advancements in technologies such as chemotherapy...","extraction_method":"llm"}}
{"subject_id":"prov:924d3adce9f1416186db5a6852571ed0","object_id":"prov:b47d137e71d54c63899020673b04c42e","predicate":"treats","confidence":0.8,"source_documents":["PMC12775696"],"created_at":"2026-01-23T04:27:01.354340+00:00","properties":{"evidence":"Despite significant advancements of lung cancer treatment in recent years, thanks to advancements in technologies such as chemotherapy...","extraction_method":"llm"}}
{"subject_id":"prov:f530e8ae12a64f0997212220bf8f4f99","object_id":"prov:8b8e352ecaab473a8ae5e43f2c11456b","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12775696"],"created_at":"2026-01-23T04:27:01.354354+00:00","properties":{"evidence":"Ferroptosis, dependent on iron and accompanied by lipid peroxidation, is a unique form of cell death.","extraction_method":"llm"}}
{"subject_id":"prov:f530e8ae12a64f0997212220bf8f4f99","object_id":"prov:b24507f8b8664ec99206d5c6c48eef76","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12775696"],"created_at":"2026-01-23T04:27:01.354362+00:00","properties":{"evidence":"Ferroptosis, dependent on iron and accompanied by lipid peroxidation, is a unique form of cell death.","extraction_method":"llm"}}
{"subject_id":"prov:f530e8ae12a64f0997212220bf8f4f99","object_id":"prov:8b8e352ecaab473a8ae5e43f2c11456b","predicate":"inhibits","confidence":0.8,"source_documents":["PMC12775696"],"created_at":"2026-01-23T04:27:01.354366+00:00","properties":{"evidence":"Core pathways, including the glutathione peroxidase 4 (GPX4)-glutathione (GSH) axis...","extraction_method":"llm"}}
{"subject_id":"prov:f530e8ae12a64f0997212220bf8f4f99","object_id":"prov:b24507f8b8664ec99206d5c6c48eef76","predicate":"inhibits","confidence":0.8,"source_documents":["PMC12775696"],"created_at":"2026-01-23T04:27:01.354370+00:00","properties":{"evidence":"Core pathways, including the glutathione peroxidase 4 (GPX4)-glutathione (GSH) axis...","extraction_method":"llm"}}
{"subject_id":"prov:f530e8ae12a64f0997212220bf8f4f99","object_id":"prov:b9d6da461e0a428eb7b82e59b62f3dde","predicate":"inhibits","confidence":0.8,"source_documents":["PMC12775696"],"created_at":"2026-01-23T04:27:01.354377+00:00","properties":{"evidence":"Core pathways, including the glutathione peroxidase 4 (GPX4)-glutathione (GSH) axis...","extraction_method":"llm"}}
{"subject_id":"prov:f530e8ae12a64f0997212220bf8f4f99","object_id":"prov:924d3adce9f1416186db5a6852571ed0","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12775696"],"created_at":"2026-01-23T04:27:01.354382+00:00","properties":{"evidence":"Here, we describe in detail the mechanisms of ferroptosis and elucidate its promising therapeutic role of modulating ferroptosis in countering lung cancer resistance to conventional therapies...","extraction_method":"llm"}}
{"subject_id":"prov:22c2148c52064a15971a6b499c598eae","object_id":"prov:924d3adce9f1416186db5a6852571ed0","predicate":"treats","confidence":0.8,"source_documents":["PMC12775696"],"created_at":"2026-01-23T04:27:01.354386+00:00","properties":{"evidence":"Here, we describe in detail the mechanisms of ferroptosis and elucidate its promising therapeutic role of modulating ferroptosis in countering lung cancer resistance to conventional therapies...","extraction_method":"llm"}}
{"subject_id":"prov:762911736f1f4787afcfc8ab8fa79b0a","object_id":"prov:924d3adce9f1416186db5a6852571ed0","predicate":"treats","confidence":0.8,"source_documents":["PMC12775696"],"created_at":"2026-01-23T04:27:01.354389+00:00","properties":{"evidence":"Here, we describe in detail the mechanisms of ferroptosis and elucidate its promising therapeutic role of modulating ferroptosis in countering lung cancer resistance to conventional therapies...","extraction_method":"llm"}}
{"subject_id":"prov:b47d137e71d54c63899020673b04c42e","object_id":"prov:924d3adce9f1416186db5a6852571ed0","predicate":"treats","confidence":0.8,"source_documents":["PMC12775696"],"created_at":"2026-01-23T04:27:01.354396+00:00","properties":{"evidence":"Here, we describe in detail the mechanisms of ferroptosis and elucidate its promising therapeutic role of modulating ferroptosis in countering lung cancer resistance to conventional therapies...","extraction_method":"llm"}}
{"subject_id":"prov:eec318d705b4454e8c6861b5f3f1b698","object_id":"prov:6409e0516c1c4bed810968ea5dfed17f","predicate":"causes","confidence":0.9,"source_documents":["PMC12776606"],"created_at":"2026-01-23T04:27:03.772959+00:00","properties":{"evidence":"Contributions of repetitive element transcription towards cancer initiation, and the mechanisms by which cancer cells evade lethal viral mimicry responses during tumor initiation remain poorly understood.","extraction_method":"llm"}}
{"subject_id":"prov:feb0205d59144895a71b53eedc96d1b6","object_id":"prov:b2dd8f3ce32f40279ca88ed4e3e51a79","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12778157"],"created_at":"2026-01-23T04:27:46.370173+00:00","properties":{"evidence":"Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), 1st identified in breast cancer and subsequently in multiple other cancer types,","extraction_method":"llm"}}
{"subject_id":"prov:5cc31ccf17ea4cbb8cc4f1c1afac62cb","object_id":"prov:b2dd8f3ce32f40279ca88ed4e3e51a79","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12778157"],"created_at":"2026-01-23T04:27:46.370194+00:00","properties":{"evidence":"Homologous recombination deficiency (HRD) has gained clinical relevance with therapeutic vulnerability, particularly in breast and ovarian cancers.","extraction_method":"llm"}}
{"subject_id":"prov:feb0205d59144895a71b53eedc96d1b6","object_id":"prov:efe7ad5b4a9f476a895ca14554d7ba0d","predicate":"increases_risk","confidence":0.8,"source_documents":["PMC12778157"],"created_at":"2026-01-23T04:27:46.370200+00:00","properties":{"evidence":"particularly in breast and ovarian cancers","extraction_method":"llm"}}
{"subject_id":"prov:5cc31ccf17ea4cbb8cc4f1c1afac62cb","object_id":"prov:efe7ad5b4a9f476a895ca14554d7ba0d","predicate":"increases_risk","confidence":0.8,"source_documents":["PMC12778157"],"created_at":"2026-01-23T04:27:46.370204+00:00","properties":{"evidence":"particularly in breast and ovarian cancers","extraction_method":"llm"}}
{"subject_id":"prov:feb0205d59144895a71b53eedc96d1b6","object_id":"prov:c532504f56834c40b2e5339459c71697","predicate":"associated_with","confidence":0.7,"source_documents":["PMC12778157"],"created_at":"2026-01-23T04:27:46.370209+00:00","properties":{"evidence":"Significant survival differences were observed in patients with adrenocortical carcinoma,","extraction_method":"llm"}}
{"subject_id":"prov:5cc31ccf17ea4cbb8cc4f1c1afac62cb","object_id":"prov:c532504f56834c40b2e5339459c71697","predicate":"associated_with","confidence":0.7,"source_documents":["PMC12778157"],"created_at":"2026-01-23T04:27:46.370213+00:00","properties":{"evidence":"Significant survival differences were observed in patients with adrenocortical carcinoma,","extraction_method":"llm"}}
{"subject_id":"prov:feb0205d59144895a71b53eedc96d1b6","object_id":"prov:5f54a0848deb430987ea38edd526bd7a","predicate":"associated_with","confidence":0.7,"source_documents":["PMC12778157"],"created_at":"2026-01-23T04:27:46.370218+00:00","properties":{"evidence":"Significant survival differences were observed in patients with chromophobe renal cell carcinoma,","extraction_method":"llm"}}
{"subject_id":"prov:5cc31ccf17ea4cbb8cc4f1c1afac62cb","object_id":"prov:5f54a0848deb430987ea38edd526bd7a","predicate":"associated_with","confidence":0.7,"source_documents":["PMC12778157"],"created_at":"2026-01-23T04:27:46.370235+00:00","properties":{"evidence":"Significant survival differences were observed in patients with chromophobe renal cell carcinoma,","extraction_method":"llm"}}
{"subject_id":"prov:feb0205d59144895a71b53eedc96d1b6","object_id":"prov:f7b0f452e8e84a4cac4e1776cc05364a","predicate":"associated_with","confidence":0.7,"source_documents":["PMC12778157"],"created_at":"2026-01-23T04:27:46.370239+00:00","properties":{"evidence":"Significant survival differences were observed in patients with low grade glioma,","extraction_method":"llm"}}
{"subject_id":"prov:5cc31ccf17ea4cbb8cc4f1c1afac62cb","object_id":"prov:f7b0f452e8e84a4cac4e1776cc05364a","predicate":"associated_with","confidence":0.7,"source_documents":["PMC12778157"],"created_at":"2026-01-23T04:27:46.370245+00:00","properties":{"evidence":"Significant survival differences were observed in patients with low grade glioma,","extraction_method":"llm"}}
{"subject_id":"prov:feb0205d59144895a71b53eedc96d1b6","object_id":"prov:fee88f23224f49afa7ba317d0b044b9d","predicate":"associated_with","confidence":0.7,"source_documents":["PMC12778157"],"created_at":"2026-01-23T04:27:46.370250+00:00","properties":{"evidence":"Significant survival differences were observed in patients with mesothelioma,","extraction_method":"llm"}}
{"subject_id":"prov:5cc31ccf17ea4cbb8cc4f1c1afac62cb","object_id":"prov:fee88f23224f49afa7ba317d0b044b9d","predicate":"associated_with","confidence":0.7,"source_documents":["PMC12778157"],"created_at":"2026-01-23T04:27:46.370253+00:00","properties":{"evidence":"Significant survival differences were observed in patients with mesothelioma,","extraction_method":"llm"}}
{"subject_id":"prov:61fe0b876bb047f189c794f2bb2e929b","object_id":"prov:2abeba20191c412ba5a87062c5154170","predicate":"causes","confidence":0.9,"source_documents":["PMC12779267"],"created_at":"2026-01-23T04:27:57.542882+00:00","properties":{"evidence":"mutations in which greatly increase risks for many tumors in carriers, most notably breast cancer.","extraction_method":"llm"}}
{"subject_id":"prov:832e0c2a359046b4af22f92857d68f44","object_id":"prov:cf893046f2d54fd691a5214fcd118f8b","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12780001"],"created_at":"2026-01-23T04:28:06.755409+00:00","properties":{"evidence":"Five key biomarkers (PSA, HER2, CEA, CA-125, AFP) were selected based on STRING-based protein-protein interaction (PPI) analysis and KEGG pathway enrichment.","extraction_method":"llm"}}
{"subject_id":"prov:ce7ed24d98c24d13a575d8983bf5812f","object_id":"prov:cf893046f2d54fd691a5214fcd118f8b","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12780001"],"created_at":"2026-01-23T04:28:06.755433+00:00","properties":{"evidence":"Five key biomarkers (PSA, HER2, CEA, CA-125, AFP) were selected based on STRING-based protein-protein interaction (PPI) analysis and KEGG pathway enrichment.","extraction_method":"llm"}}
{"subject_id":"prov:1127e8bfa39d44f79a9cb0672383336e","object_id":"prov:cf893046f2d54fd691a5214fcd118f8b","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12780001"],"created_at":"2026-01-23T04:28:06.755452+00:00","properties":{"evidence":"Five key biomarkers (PSA, HER2, CEA, CA-125, AFP) were selected based on STRING-based protein-protein interaction (PPI) analysis and KEGG pathway enrichment.","extraction_method":"llm"}}
{"subject_id":"prov:3d1895bd441b466d91fc349f5b315a6e","object_id":"prov:cf893046f2d54fd691a5214fcd118f8b","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12780001"],"created_at":"2026-01-23T04:28:06.755462+00:00","properties":{"evidence":"Five key biomarkers (PSA, HER2, CEA, CA-125, AFP) were selected based on STRING-based protein-protein interaction (PPI) analysis and KEGG pathway enrichment.","extraction_method":"llm"}}
{"subject_id":"prov:56b646eb266d4d34992833be1302bc36","object_id":"prov:cf893046f2d54fd691a5214fcd118f8b","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12780001"],"created_at":"2026-01-23T04:28:06.755471+00:00","properties":{"evidence":"Five key biomarkers (PSA, HER2, CEA, CA-125, AFP) were selected based on STRING-based protein-protein interaction (PPI) analysis and KEGG pathway enrichment.","extraction_method":"llm"}}
{"subject_id":"prov:4fffeb4e2ea84b4f809c3ce90fa2ab2f","object_id":"prov:90bd8e9781384ff4983e8585c855f509","predicate":"treats","confidence":0.9,"source_documents":["PMC12780067"],"created_at":"2026-01-23T04:28:10.625243+00:00","properties":{"evidence":"Nanoparticle-based therapies have emerged as promising alternatives to overcome these challenges.","extraction_method":"llm"}}
{"subject_id":"prov:51c31c395d554557b02e76749f45b7df","object_id":"prov:8a7c0f0b134e4c9ab6339ed032fe448c","predicate":"causes","confidence":0.9,"source_documents":["PMC12780394"],"created_at":"2026-01-23T04:28:14.632881+00:00","properties":{"evidence":"BackgroundPleural mesothelioma (PM) is an aggressive malignancy that originates on the mesothelial surface of the pleura,","extraction_method":"llm"}}
{"subject_id":"prov:51c31c395d554557b02e76749f45b7df","object_id":"prov:6c177c7d65ed48499cdd2697f3119c04","predicate":"causes","confidence":0.9,"source_documents":["PMC12780394"],"created_at":"2026-01-23T04:28:14.632907+00:00","properties":{"evidence":"BackgroundPleural mesothelioma (PM) is an aggressive malignancy that originates on the mesothelial surface of the pleura, peritoneum,","extraction_method":"llm"}}
{"subject_id":"prov:51c31c395d554557b02e76749f45b7df","object_id":"prov:01fad537806343428e0f193a04ea2ab9","predicate":"causes","confidence":0.9,"source_documents":["PMC12780394"],"created_at":"2026-01-23T04:28:14.632916+00:00","properties":{"evidence":"BackgroundPleural mesothelioma (PM) is an aggressive malignancy that originates on the mesothelial surface of the pleura, peritoneum, pericardium,","extraction_method":"llm"}}
{"subject_id":"prov:51c31c395d554557b02e76749f45b7df","object_id":"prov:2a3ed15d97af4f62b8aefc9eaebee9e8","predicate":"causes","confidence":0.9,"source_documents":["PMC12780394"],"created_at":"2026-01-23T04:28:14.632935+00:00","properties":{"evidence":"BackgroundPleural mesothelioma (PM) is an aggressive malignancy that originates on the mesothelial surface of the pleura, peritoneum, pericardium, and tunica vaginalis.","extraction_method":"llm"}}
{"subject_id":"prov:026bef76bb524d899d03fe791e362c45","object_id":"prov:03a81695a89a4990929ea8a6f96cd4c3","predicate":"treats","confidence":0.9,"source_documents":["PMC12780783"],"created_at":"2026-01-23T04:28:27.434361+00:00","properties":{"evidence":"Contemporary early management strategies emphasize breast-conserving surgery and selective axillary surgery, alongside the expanded application of hypofractionated and precision-targeted radiotherapy.","extraction_method":"llm"}}
{"subject_id":"prov:026bef76bb524d899d03fe791e362c45","object_id":"prov:9a9bceb69d3945fb825216bfdd5c1d57","predicate":"treats","confidence":0.9,"source_documents":["PMC12780783"],"created_at":"2026-01-23T04:28:27.434387+00:00","properties":{"evidence":"Contemporary early management strategies emphasize breast-conserving surgery and selective axillary surgery, alongside the expanded application of hypofractionated and precision-targeted radiotherapy.","extraction_method":"llm"}}
{"subject_id":"prov:026bef76bb524d899d03fe791e362c45","object_id":"prov:b1b43ccb9c42413fa4d39d018472d656","predicate":"diagnosed_by","confidence":0.8,"source_documents":["PMC12780783"],"created_at":"2026-01-23T04:28:27.434397+00:00","properties":{"evidence":"Screening practices are increasingly evolving towards stratified, risk-adapted pathways. These approaches often combine mammography with adjunct imaging modalities such as ultrasound, digital breast tomosynthesis, or magnetic resonance imaging for selected populations,","extraction_method":"llm"}}
{"subject_id":"prov:026bef76bb524d899d03fe791e362c45","object_id":"prov:8d604a33374e443bb3b3c706e212a697","predicate":"diagnosed_by","confidence":0.8,"source_documents":["PMC12780783"],"created_at":"2026-01-23T04:28:27.434405+00:00","properties":{"evidence":"Screening practices are increasingly evolving towards stratified, risk-adapted pathways. These approaches often combine mammography with adjunct imaging modalities such as ultrasound, digital breast tomosynthesis, or magnetic resonance imaging for selected populations,","extraction_method":"llm"}}
{"subject_id":"prov:026bef76bb524d899d03fe791e362c45","object_id":"prov:979f84930589418a8773212d713f6637","predicate":"diagnosed_by","confidence":0.8,"source_documents":["PMC12780783"],"created_at":"2026-01-23T04:28:27.434412+00:00","properties":{"evidence":"Screening practices are increasingly evolving towards stratified, risk-adapted pathways. These approaches often combine mammography with adjunct imaging modalities such as ultrasound, digital breast tomosynthesis, or magnetic resonance imaging for selected populations,","extraction_method":"llm"}}
{"subject_id":"prov:026bef76bb524d899d03fe791e362c45","object_id":"prov:0675540e6c7a418ea136234593a469c5","predicate":"diagnosed_by","confidence":0.8,"source_documents":["PMC12780783"],"created_at":"2026-01-23T04:28:27.434419+00:00","properties":{"evidence":"Screening practices are increasingly evolving towards stratified, risk-adapted pathways. These approaches often combine mammography with adjunct imaging modalities such as ultrasound, digital breast tomosynthesis, or magnetic resonance imaging for selected populations,","extraction_method":"llm"}}
{"subject_id":"prov:026bef76bb524d899d03fe791e362c45","object_id":"prov:bf0bc75a110248889d38833160252932","predicate":"associated_with","confidence":0.7,"source_documents":["PMC12780783"],"created_at":"2026-01-23T04:28:27.434426+00:00","properties":{"evidence":"These approaches often combine mammography with adjunct imaging modalities such as ultrasound, digital breast tomosynthesis, or magnetic resonance imaging for selected populations, while artificial intelligence is under active investigation to enhance image interpretation and streamline workflow.","extraction_method":"llm"}}
{"subject_id":"prov:7517e315cad9400f8d4f656d8795bbb2","object_id":"prov:47ed2f08188340729eb9c38592cfe56d","predicate":"treats","confidence":0.9,"source_documents":["PMC12781513"],"created_at":"2026-01-23T04:28:32.655752+00:00","properties":{"evidence":"The anthracycline-based regimen led to decreased core fucosylation and digalactosylation.","extraction_method":"llm"}}
{"subject_id":"prov:5107f65ddb3d476d83c5ddd9e7ea2283","object_id":"prov:47ed2f08188340729eb9c38592cfe56d","predicate":"treats","confidence":0.9,"source_documents":["PMC12781513"],"created_at":"2026-01-23T04:28:32.655784+00:00","properties":{"evidence":"The greatest reduction in core fucosylation was observed in patients treated with docetaxel and cyclophosphamide.","extraction_method":"llm"}}
{"subject_id":"prov:94fd4fa3beca490295a9c221ef72ed6b","object_id":"prov:47ed2f08188340729eb9c38592cfe56d","predicate":"treats","confidence":0.9,"source_documents":["PMC12781513"],"created_at":"2026-01-23T04:28:32.655793+00:00","properties":{"evidence":"The greatest reduction in core fucosylation was observed in patients treated with docetaxel and cyclophosphamide.","extraction_method":"llm"}}
{"subject_id":"prov:3c0708ac73494d838fbb1a1095f34e48","object_id":"prov:47ed2f08188340729eb9c38592cfe56d","predicate":"treats","confidence":0.9,"source_documents":["PMC12781513"],"created_at":"2026-01-23T04:28:32.655801+00:00","properties":{"evidence":"This study investigated changes in N-glycosylation of immunoglobulin G (IgG) and total plasma proteins in patients with breast cancer undergoing neoadjuvant chemotherapy.","extraction_method":"llm"}}
{"subject_id":"prov:072d4d44f88c4770ab7d4c53a7a1c4e3","object_id":"prov:dbc18677f62c47eda3bd673c2743b6bf","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12782189"],"created_at":"2026-01-23T04:28:40.004799+00:00","properties":{"evidence":"Number of previous patient portal logins (UHealth average marginal effect [AME]: 0.32; 95% CI: 0.27, 0.38; NYULH AME: 0.33; 95% CI: 0.27, 0.39), having a recorded primary care provider (NYULH AME: 0.15; 95% CI: 0.08, 0.22), and more primary care visits in the previous three years (NYULH AME: 0.09; 95% CI: 0.02, 0.16) were associated with opening patient portal messages about genetic services.","extraction_method":"llm"}}
{"subject_id":"prov:072d4d44f88c4770ab7d4c53a7a1c4e3","object_id":"prov:b4299a7702574dafaf02ac97018a79a9","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12782189"],"created_at":"2026-01-23T04:28:40.004828+00:00","properties":{"evidence":"Number of previous patient portal logins (UHealth average marginal effect [AME]: 0.32; 95% CI: 0.27, 0.38; NYULH AME: 0.33; 95% CI: 0.27, 0.39), having a recorded primary care provider (NYULH AME: 0.15; 95% CI: 0.08, 0.22), and more primary care visits in the previous three years (NYULH AME: 0.09; 95% CI: 0.02, 0.16) were associated with opening patient portal messages about genetic services.","extraction_method":"llm"}}
{"subject_id":"prov:072d4d44f88c4770ab7d4c53a7a1c4e3","object_id":"prov:d3db7b0e22c14afb9ffcedf8d02d4487","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12782189"],"created_at":"2026-01-23T04:28:40.004837+00:00","properties":{"evidence":"Eligible patients had a primary care visit in the previous three years, patient portal account, no prior cancer diagnosis except non-melanoma skin cancer,","extraction_method":"llm"}}
{"subject_id":"prov:dbc18677f62c47eda3bd673c2743b6bf","object_id":"prov:b4299a7702574dafaf02ac97018a79a9","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12782189"],"created_at":"2026-01-23T04:28:40.004845+00:00","properties":{"evidence":"Between 2020–2023, 3,073 eligible primary care patients aged 25–60 years meeting family history-based criteria for cancer genetic evaluation were randomized 1:1 to receive a patient portal message with a hyperlink to a pre-test genetics education chatbot or information about scheduling a pre-test standard of care (SOC) appointment.","extraction_method":"llm"}}
{"subject_id":"prov:dbc18677f62c47eda3bd673c2743b6bf","object_id":"prov:072d4d44f88c4770ab7d4c53a7a1c4e3","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12782189"],"created_at":"2026-01-23T04:28:40.004864+00:00","properties":{"evidence":"Between 2020–2023, 3,073 eligible primary care patients aged 25–60 years meeting family history-based criteria for cancer genetic evaluation were randomized 1:1 to receive a patient portal message with a hyperlink to a pre-test genetics education chatbot or information about scheduling a pre-test standard of care (SOC) appointment.","extraction_method":"llm"}}
{"subject_id":"prov:b4299a7702574dafaf02ac97018a79a9","object_id":"prov:dbc18677f62c47eda3bd673c2743b6bf","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12782189"],"created_at":"2026-01-23T04:28:40.004872+00:00","properties":{"evidence":"Between 2020–2023, 3,073 eligible primary care patients aged 25–60 years meeting family history-based criteria for cancer genetic evaluation were randomized 1:1 to receive a patient portal message with a hyperlink to a pre-test genetics education chatbot or information about scheduling a pre-test standard of care (SOC) appointment.","extraction_method":"llm"}}
{"subject_id":"prov:b4299a7702574dafaf02ac97018a79a9","object_id":"prov:072d4d44f88c4770ab7d4c53a7a1c4e3","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12782189"],"created_at":"2026-01-23T04:28:40.004880+00:00","properties":{"evidence":"Between 2020–2023, 3,073 eligible primary care patients aged 25–60 years meeting family history-based criteria for cancer genetic evaluation were randomized 1:1 to receive a patient portal message with a hyperlink to a pre-test genetics education chatbot or information about scheduling a pre-test standard of care (SOC) appointment.","extraction_method":"llm"}}
{"subject_id":"prov:d3db7b0e22c14afb9ffcedf8d02d4487","object_id":"prov:072d4d44f88c4770ab7d4c53a7a1c4e3","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12782189"],"created_at":"2026-01-23T04:28:40.004886+00:00","properties":{"evidence":"Eligible patients had a primary care visit in the previous three years, patient portal account, no prior cancer diagnosis except non-melanoma skin cancer,","extraction_method":"llm"}}
{"subject_id":"prov:d47afd23e9574feea53f7fc8c6dd8644","object_id":"prov:ea9313ebd4a744ada10266b705953052","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12783552"],"created_at":"2026-01-23T04:28:45.171760+00:00","properties":{"evidence":"While PSA testing can reduce mortality, there is potential for over-detection of indolent prostate cancer that would never become clinically important.","extraction_method":"llm"}}
{"subject_id":"prov:defe0aa3a1234861976a4166c970872f","object_id":"prov:ea9313ebd4a744ada10266b705953052","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12783552"],"created_at":"2026-01-23T04:28:45.171780+00:00","properties":{"evidence":"Thus, research is needed to understand individual genetic risk profiles among unaffected men to help guide personalized PSA screening.","extraction_method":"llm"}}
{"subject_id":"prov:d47afd23e9574feea53f7fc8c6dd8644","object_id":"prov:defe0aa3a1234861976a4166c970872f","predicate":"associated_with","confidence":0.8,"source_documents":["PMC12783552"],"created_at":"2026-01-23T04:28:45.171786+00:00","properties":{"evidence":"This pilot study explored recruitment outcomes, genetic risk perceptions, and willingness to provide a biospecimen (saliva sample) for prostate cancer genetic risk testing among unaffected men.","extraction_method":"llm"}}
{"subject_id":"prov:32d7f1545b224412ab4f9e75b406e23f","object_id":"prov:dd18347e15104202bcf30c437b3c704e","predicate":"treats","confidence":0.9,"source_documents":["PMC12784210"],"created_at":"2026-01-23T04:28:48.276028+00:00","properties":{"evidence":"However, the molecular mechanism of the downregulation of BRD7 expression and whether the strategy of activating BRD7 expression plays anti‐tumour effects still needs to be clarified.","extraction_method":"llm"}}
{"subject_id":"prov:32d7f1545b224412ab4f9e75b406e23f","object_id":"prov:dd18347e15104202bcf30c437b3c704e","predicate":"increases_risk","confidence":0.8,"source_documents":["PMC12784210"],"created_at":"2026-01-23T04:28:48.276064+00:00","properties":{"evidence":"In addition, BRD7 had hypermethylation modification in its promoter and decreased expression in NPC tissues, and both of them were negatively correlated,","extraction_method":"llm"}}
{"subject_id":"prov:fa267a696d0449c687710123165b92bf","object_id":"prov:b0505a2114fd4a47a2b898da0a5cf68b","predicate":"causes","confidence":0.9,"source_documents":["PMC12784249"],"created_at":"2026-01-23T04:28:50.417917+00:00","properties":{"evidence":"We analyzed tumor suppressors in cancer cell lines and identified lethal gene knock-in strategies.","extraction_method":"llm"}}
{"subject_id":"prov:84823c48a4644f53aa46a1ad2c9fa864","object_id":"prov:fa267a696d0449c687710123165b92bf","predicate":"associated_with","confidence":0.8,"source_documents":["PMC12784249"],"created_at":"2026-01-23T04:28:50.417940+00:00","properties":{"evidence":"The gMCSpy Python package now includes gMIS functionalities to assess the landscape of lethal genetic interactions in human cells.","extraction_method":"llm"}}
{"subject_id":"prov:be5e41974fec49d1ac9abf7903576bd2","object_id":"prov:902a93f6761b44648d5b77f7b74ba5c3","predicate":"interacts_with","confidence":0.9,"source_documents":["PMC12784584"],"created_at":"2026-01-23T04:28:53.297619+00:00","properties":{"evidence":"Docking showed strong affinities of Apigenin for PARP1 (–9.6 kcal/mol) and GNT for ESR1 (–8.3 kcal/mol)","extraction_method":"llm"}}
{"subject_id":"prov:be5e41974fec49d1ac9abf7903576bd2","object_id":"prov:6f1de013341d48bda31a1c367e4cda6a","predicate":"interacts_with","confidence":0.9,"source_documents":["PMC12784584"],"created_at":"2026-01-23T04:28:53.297647+00:00","properties":{"evidence":"Docking showed strong affinities of Apigenin for PARP1 (–9.6 kcal/mol) and GNT for ESR1 (–8.3 kcal/mol)","extraction_method":"llm"}}
{"subject_id":"prov:8e6a946840b4468bba20ead6ca6d1f30","object_id":"prov:902a93f6761b44648d5b77f7b74ba5c3","predicate":"interacts_with","confidence":0.9,"source_documents":["PMC12784584"],"created_at":"2026-01-23T04:28:53.297658+00:00","properties":{"evidence":"Docking showed strong affinities of Apigenin for PARP1 (–9.6 kcal/mol) and GNT for ESR1 (–8.3 kcal/mol)","extraction_method":"llm"}}
{"subject_id":"prov:be5e41974fec49d1ac9abf7903576bd2","object_id":"prov:cc0abf27bc8e4ab48f7b8c435d5d42d3","predicate":"treats","confidence":0.9,"source_documents":["PMC12784584"],"created_at":"2026-01-23T04:28:53.297666+00:00","properties":{"evidence":"BackgroundBreast cancer remains a leading cause of cancer-related mortality among women worldwide","extraction_method":"llm"}}
{"subject_id":"prov:8e6a946840b4468bba20ead6ca6d1f30","object_id":"prov:cc0abf27bc8e4ab48f7b8c435d5d42d3","predicate":"treats","confidence":0.9,"source_documents":["PMC12784584"],"created_at":"2026-01-23T04:28:53.297686+00:00","properties":{"evidence":"BackgroundBreast cancer remains a leading cause of cancer-related mortality among women worldwide","extraction_method":"llm"}}
{"subject_id":"prov:75e87e3b8b6649dc99100059bc94e1a6","object_id":"prov:5094b1679abf4aeab37e614936794678","predicate":"causes","confidence":0.9,"source_documents":["PMC12784769"],"created_at":"2026-01-23T04:28:56.207872+00:00","properties":{"evidence":"Impaired estrogen signaling caused by either endogenous or environmental factors alarms the hypothalamus...","extraction_method":"llm"}}
{"subject_id":"prov:5094b1679abf4aeab37e614936794678","object_id":"prov:75e87e3b8b6649dc99100059bc94e1a6","predicate":"indicates","confidence":0.8,"source_documents":["PMC12784769"],"created_at":"2026-01-23T04:28:56.207925+00:00","properties":{"evidence":"Hyperinsulinemia is a subtle signal of the genome that indicates successful restoration of estrogen signaling at the expense of excessive insulin synthesis.","extraction_method":"llm"}}
{"subject_id":"prov:75e87e3b8b6649dc99100059bc94e1a6","object_id":"prov:91603328a186482f996d1635118c2eb0","predicate":"causes","confidence":0.9,"source_documents":["PMC12784769"],"created_at":"2026-01-23T04:28:56.207945+00:00","properties":{"evidence":"Over time, the strengthening defect in estrogen signaling and impaired glucose uptake result in metabolic syndrome...","extraction_method":"llm"}}
{"subject_id":"prov:75e87e3b8b6649dc99100059bc94e1a6","object_id":"prov:179cfb5686614368b85f80de54383ed8","predicate":"causes","confidence":0.9,"source_documents":["PMC12784769"],"created_at":"2026-01-23T04:28:56.207977+00:00","properties":{"evidence":"The complete breakdown of estrogen signaling results in DNA damage and cancer initiation in the affected organ.","extraction_method":"llm"}}
{"subject_id":"prov:75e87e3b8b6649dc99100059bc94e1a6","object_id":"prov:2b7ca92265554c889f1a7e78d5917686","predicate":"causes","confidence":0.9,"source_documents":["PMC12784769"],"created_at":"2026-01-23T04:28:56.207982+00:00","properties":{"evidence":"The complete breakdown of estrogen signaling results in DNA damage and cancer initiation in the affected organ.","extraction_method":"llm"}}
{"subject_id":"prov:e4898f93cf104c0dab9e752c998e30aa","object_id":"prov:9a0ddea30ed1441fbe58a222f543839d","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12784773"],"created_at":"2026-01-23T04:28:57.772172+00:00","properties":{"evidence":"In cancer, ferroptosis can play a “double-edged sword” role, where it can be either beneficial or detrimental.","extraction_method":"llm"}}
{"subject_id":"prov:e4898f93cf104c0dab9e752c998e30aa","object_id":"prov:9a0ddea30ed1441fbe58a222f543839d","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12784773"],"created_at":"2026-01-23T04:28:57.772190+00:00","properties":{"evidence":"There are several factors of ferroptosis that can either promote or prevent cancer from occurring.","extraction_method":"llm"}}
{"subject_id":"prov:e4898f93cf104c0dab9e752c998e30aa","object_id":"prov:9a0ddea30ed1441fbe58a222f543839d","predicate":"prevents","confidence":0.8,"source_documents":["PMC12784773"],"created_at":"2026-01-23T04:28:57.772196+00:00","properties":{"evidence":"There are several factors of ferroptosis that can either promote or prevent cancer from occurring.","extraction_method":"llm"}}
{"subject_id":"prov:b32892e6c5404e8ab843c0cf29237299","object_id":"prov:2d4934290a40480f9cb6929cd3c1dcf3","predicate":"treats","confidence":0.9,"source_documents":["PMC12785006"],"created_at":"2026-01-23T04:28:59.483495+00:00","properties":{"evidence":"Aromatase inhibitors (AIs) are frequently used to treat menopausal or postmenopausal patients with estrogen-positive breast cancer.","extraction_method":"llm"}}
{"subject_id":"prov:b32892e6c5404e8ab843c0cf29237299","object_id":"prov:a0bcc30decd84197b95dddf7bfa0ac0e","predicate":"treats","confidence":0.9,"source_documents":["PMC12785006"],"created_at":"2026-01-23T04:28:59.483517+00:00","properties":{"evidence":"Aromatase inhibitors (AIs) are frequently used to treat menopausal or postmenopausal patients with estrogen-positive breast cancer.","extraction_method":"llm"}}
{"subject_id":"prov:135a6b10efb54105ba08092b47aabd5f","object_id":"prov:d283ded3a69a4f32a107ec934d3c5c48","predicate":"treats","confidence":0.9,"source_documents":["PMC12785104"],"created_at":"2026-01-23T04:29:05.423847+00:00","properties":{"evidence":"Targeted ligands, stimuli-responsive release, and stealth coatings are key design principles which are demonstrated alongside applications in magnetic resonance imaging (MRI)","extraction_method":"llm"}}
{"subject_id":"prov:135a6b10efb54105ba08092b47aabd5f","object_id":"prov:7aee9d44b59b4904bb67209e0e1f8e4b","predicate":"treats","confidence":0.9,"source_documents":["PMC12785104"],"created_at":"2026-01-23T04:29:05.423906+00:00","properties":{"evidence":"Targeted ligands, stimuli-responsive release, and stealth coatings are key design principles which are demonstrated alongside applications in positron emission tomography (PET)/single-photon emission computed tomography (SPECT)","extraction_method":"llm"}}
{"subject_id":"prov:135a6b10efb54105ba08092b47aabd5f","object_id":"prov:2b82f7e872e946c09312f1c0b5b0349c","predicate":"treats","confidence":0.9,"source_documents":["PMC12785104"],"created_at":"2026-01-23T04:29:05.423954+00:00","properties":{"evidence":"Targeted ligands, stimuli-responsive release, and stealth coatings are key design principles which are demonstrated alongside applications in near-infrared imaging (NIR)","extraction_method":"llm"}}
{"subject_id":"prov:135a6b10efb54105ba08092b47aabd5f","object_id":"prov:e555efbdbf1d4650a54e9faf66cc99b6","predicate":"treats","confidence":0.9,"source_documents":["PMC12785104"],"created_at":"2026-01-23T04:29:05.423971+00:00","properties":{"evidence":"Targeted ligands, stimuli-responsive release, and stealth coatings are key design principles which are demonstrated alongside applications in ultrasound","extraction_method":"llm"}}
{"subject_id":"prov:135a6b10efb54105ba08092b47aabd5f","object_id":"prov:8b01bbb289504bcfad943f1c09da6ca9","predicate":"treats","confidence":0.9,"source_documents":["PMC12785104"],"created_at":"2026-01-23T04:29:05.423985+00:00","properties":{"evidence":"Targeted ligands, stimuli-responsive release, and stealth coatings are key design principles which are demonstrated alongside applications in multimodal imaging","extraction_method":"llm"}}
{"subject_id":"prov:ff53f3c30fb94edfb02c75cf0bc998d7","object_id":"prov:f559837586564292bd86fec3847f946d","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12785246"],"created_at":"2026-01-23T04:29:12.284468+00:00","properties":{"evidence":"The transcription factor SOX11 is implicated in tumor progression across multiple types of cancers, including head and neck squamous cell carcinoma (HNSCC).","extraction_method":"llm"}}
{"subject_id":"prov:5eeb6764de674268bdbae4654e0684cb","object_id":"prov:ff53f3c30fb94edfb02c75cf0bc998d7","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12785246"],"created_at":"2026-01-23T04:29:12.284502+00:00","properties":{"evidence":"In this study, we found that the expression of SOX11 was induced by epidermal growth factor (EGF) but suppressed by an epidermal growth factor receptor (EGFR) inhibitor in HNSCC cells.","extraction_method":"llm"}}
{"subject_id":"prov:668d372a8ace4784b0f816707ef47529","object_id":"prov:ff53f3c30fb94edfb02c75cf0bc998d7","predicate":"prevents","confidence":0.9,"source_documents":["PMC12785246"],"created_at":"2026-01-23T04:29:12.284510+00:00","properties":{"evidence":"In this study, we found that the expression of SOX11 was induced by epidermal growth factor (EGF) but suppressed by an epidermal growth factor receptor (EGFR) inhibitor in HNSCC cells.","extraction_method":"llm"}}
{"subject_id":"prov:7f38f7dc297d4d7993a79c75d0929903","object_id":"prov:ff53f3c30fb94edfb02c75cf0bc998d7","predicate":"associated_with","confidence":0.9,"source_documents":["PMC12785246"],"created_at":"2026-01-23T04:29:12.284515+00:00","properties":{"evidence":"The signal transducer and activator of transcription 3 (STAT3) bound to the Sox11 gene promoter and transcriptionally upregulated the expression of Sox11 in HNSCC cells.","extraction_method":"llm"}}
{"subject_id":"prov:ff53f3c30fb94edfb02c75cf0bc998d7","object_id":"prov:f4ff4a755eb543a796f09fadfc026fd9","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12785246"],"created_at":"2026-01-23T04:29:12.284521+00:00","properties":{"evidence":"Knockdown of SOX11 significantly downregulated the expression of EMT-related genes, including EMT-TFs, vimentin, fibronectin, and N-cadherin, but significantly upregulated E-cadherin and vice versa when SOX11 was overexpressed.","extraction_method":"llm"}}
{"subject_id":"prov:ff53f3c30fb94edfb02c75cf0bc998d7","object_id":"prov:cb09159b23b645a0969c68e5bcefa062","predicate":"decreases_risk","confidence":0.9,"source_documents":["PMC12785246"],"created_at":"2026-01-23T04:29:12.284526+00:00","properties":{"evidence":"Knockdown of SOX11 significantly downregulated the expression of EMT-related genes, including EMT-TFs, vimentin, fibronectin, and N-cadherin, but significantly upregulated E-cadherin and vice versa when SOX11 was overexpressed.","extraction_method":"llm"}}
{"subject_id":"prov:ff53f3c30fb94edfb02c75cf0bc998d7","object_id":"prov:54fb3e209cec4b31a9a5936800269b21","predicate":"decreases_risk","confidence":0.9,"source_documents":["PMC12785246"],"created_at":"2026-01-23T04:29:12.284543+00:00","properties":{"evidence":"Knockdown of SOX11 significantly downregulated the expression of EMT-related genes, including EMT-TFs, vimentin, fibronectin, and N-cadherin, but significantly upregulated E-cadherin and vice versa when SOX11 was overexpressed.","extraction_method":"llm"}}
{"subject_id":"prov:ff53f3c30fb94edfb02c75cf0bc998d7","object_id":"prov:62086983eff64f7b8927fcb4c56055d2","predicate":"decreases_risk","confidence":0.9,"source_documents":["PMC12785246"],"created_at":"2026-01-23T04:29:12.284548+00:00","properties":{"evidence":"Knockdown of SOX11 significantly downregulated the expression of EMT-related genes, including EMT-TFs, vimentin, fibronectin, and N-cadherin, but significantly upregulated E-cadherin and vice versa when SOX11 was overexpressed.","extraction_method":"llm"}}
{"subject_id":"prov:949f6237530c40a486e077242e46d074","object_id":"prov:d7ba40b9d08d471eaed95b423149b563","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12785631"],"created_at":"2026-01-23T04:29:19.554522+00:00","properties":{"evidence":"There was no increase in AURKA gene copy number among the groups (2−∆∆Ct < 2).","extraction_method":"llm"}}
{"subject_id":"prov:949f6237530c40a486e077242e46d074","object_id":"prov:feb4e1fe7626466b8dc925ed6609b6c4","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12785631"],"created_at":"2026-01-23T04:29:19.554550+00:00","properties":{"evidence":"At the protein level, AURKA was significantly higher in both cancer groups compared to the control group (p < 0.001).","extraction_method":"llm"}}
{"subject_id":"prov:949f6237530c40a486e077242e46d074","object_id":"prov:b762a7a10ccb4d14aa63462b03832416","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC12785631"],"created_at":"2026-01-23T04:29:19.554566+00:00","properties":{"evidence":"There was no increase in AURKA gene copy number among the groups (2−∆∆Ct < 2).","extraction_method":"llm"}}
{"subject_id":"prov:681aa9b093d74d3c98fb6f442a9fe2bc","object_id":"prov:84d870f83e994e0f882f31f738028c25","predicate":"treats","confidence":0.9,"source_documents":["PMC12787284"],"created_at":"2026-01-23T04:29:27.628753+00:00","properties":{"evidence":"The patient received six cycles of adjuvant paclitaxel and carboplatin...","extraction_method":"llm"}}
{"subject_id":"prov:681aa9b093d74d3c98fb6f442a9fe2bc","object_id":"prov:a7a92a1561e4483fb2fb00d043d20351","predicate":"treats","confidence":0.9,"source_documents":["PMC12787284"],"created_at":"2026-01-23T04:29:27.628786+00:00","properties":{"evidence":"The patient received six cycles of adjuvant paclitaxel and carboplatin...","extraction_method":"llm"}}
{"subject_id":"prov:681aa9b093d74d3c98fb6f442a9fe2bc","object_id":"prov:5bf92b077b684ac294fce4c12dd1115b","predicate":"treats","confidence":0.9,"source_documents":["PMC12787284"],"created_at":"2026-01-23T04:29:27.628797+00:00","properties":{"evidence":"The patient received four cycles of single-agent bevacizumab for maintenance therapy.","extraction_method":"llm"}}
{"subject_id":"prov:681aa9b093d74d3c98fb6f442a9fe2bc","object_id":"prov:dfbe76a439f44c8cb1a1ead44ac0d73e","predicate":"associated_with","confidence":0.8,"source_documents":["PMC12787284"],"created_at":"2026-01-23T04:29:27.628808+00:00","properties":{"evidence":"Most previously reported cases have involved primary ovarian mucinous neoplasms containing signet-ring cells.","extraction_method":"llm"}}
{"subject_id":"prov:681aa9b093d74d3c98fb6f442a9fe2bc","object_id":"prov:e42c9afbdd9646078f6a0d9f6631a00b","predicate":"associated_with","confidence":0.8,"source_documents":["PMC12787284"],"created_at":"2026-01-23T04:29:27.628826+00:00","properties":{"evidence":"Methods: We report a unique case of advanced primary ovarian adenocarcinoma with a signet-ring cell component...","extraction_method":"llm"}}
{"subject_id":"prov:dd644d3dbe364f84b05f3f7087efb9e8","object_id":"prov:5e079c1eb7d84584bf4f35e0f9bb9c7b","predicate":"increases_risk","confidence":0.9,"source_documents":["PMC5346327"],"created_at":"2026-01-23T04:29:45.154665+00:00","properties":{"evidence":"Repeated cocaine increased PGC-1α levels","extraction_method":"llm"}}
{"subject_id":"prov:74ee472b680447aaa5fe2dca378ff2fb","object_id":"prov:3e42b569273b428b8d8459f1da131792","predicate":"associated_with","confidence":0.9,"source_documents":["PMC5748537"],"created_at":"2026-01-23T04:29:56.521585+00:00","properties":{"evidence":"(1) Background: As the U.S. healthcare system evolves from fee-for-service financing to global population-based payments designed to be accountable for both quality and total cost of care, the effective and safe use of medications is gaining increased importance.","extraction_method":"llm"}}
{"subject_id":"prov:74ee472b680447aaa5fe2dca378ff2fb","object_id":"prov:e98f897e2f244876ac1620db209bfa02","predicate":"associated_with","confidence":0.9,"source_documents":["PMC5748537"],"created_at":"2026-01-23T04:29:56.521606+00:00","properties":{"evidence":"(1) Background: As the U.S. healthcare system evolves from fee-for-service financing to global population-based payments designed to be accountable for both quality and total cost of care, the effective and safe use of medications is gaining increased importance.","extraction_method":"llm"}}
{"subject_id":"prov:74ee472b680447aaa5fe2dca378ff2fb","object_id":"prov:db515fab975248b89d5c0f35850baaf5","predicate":"associated_with","confidence":0.9,"source_documents":["PMC5748537"],"created_at":"2026-01-23T04:29:56.521613+00:00","properties":{"evidence":"(3) Results: All 15 community pharmacy sites were integrated into the HIT infrastructure through Direct Secure Messaging,","extraction_method":"llm"}}
{"subject_id":"prov:f939b9a3567a4584b72221efabd9ca54","object_id":"prov:6e297b3538fd4f1e905815e459e9c5fb","predicate":"causes","confidence":0.9,"source_documents":["PMC5961482"],"created_at":"2026-01-23T04:29:58.364208+00:00","properties":{"evidence":"Upon return to China, she developed a fever (on 8 August), and Trypanosoma brucei rhodesiense infection was confirmed by laboratory tests (on 14 August)","extraction_method":"llm"}}
{"subject_id":"prov:86104446922c44f39e37024f628010b5","object_id":"prov:6e297b3538fd4f1e905815e459e9c5fb","predicate":"treats","confidence":0.9,"source_documents":["PMC5961482"],"created_at":"2026-01-23T04:29:58.364230+00:00","properties":{"evidence":"She was treated with pentamidine followed by suramin","extraction_method":"llm"}}
{"subject_id":"prov:e0901ad673394703a233931f0f32edc2","object_id":"prov:6e297b3538fd4f1e905815e459e9c5fb","predicate":"treats","confidence":0.9,"source_documents":["PMC5961482"],"created_at":"2026-01-23T04:29:58.364236+00:00","properties":{"evidence":"She was treated with pentamidine followed by suramin","extraction_method":"llm"}}
